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Most cellular processes are controlled by proteins. Their value in sustaining 
life is difficult to overestimate. Unlike the genome, the protein content of 
the cell – the proteome – is always changing: new proteins are continuously 
produced, modified, transferred from one subcellular compartment to 
another or degraded and removed. The proteome reflects the cellular state or 
external condition encountered by a cell, and therefore determines 
biological processes and pathways at a specific point in time.1-3 The proteins 
are produced from the DNA blueprints via messenger RNA that represent 
the momentary “activity” of the genome. However, gene expression does 
not always correlate with the protein expression.4-6 Even if the mRNA is 
expressed or expressed at a different rate, the protein may not be similarly 
expressed or changed in abundance, due to post-transcriptional regulation, 
protein transport or degradation. In order to be able to study and treat 
physiological changes in cells or the entire body, transcriptomics and 
proteomics have developed in parallel and complementary to each other. 
Unfortunately, the extrapolation from the genome is limited due to lack of 
(experimental) knowledge of gene (actually protein) function and incorrect 
annotations. Proteomics, on the other hand, can be viewed as an 
experimental approach to explain the information contained in genomic 
sequences in terms of their expression, subcellular localization, structure, 
interactions, biochemical functions and states of modification, all of which 
are interrelated. These aspects of proteins are all more or less amenable to a 
proteomics approach, the most difficult being structural determination and 
biochemical properties, which usually requires substantial amounts of the 
proteins to be purified. In the other words, proteomics attempts to study 
biological processes comprehensively by the systematic analysis of the 
proteins expressed in a cell or tissue. 
Mass spectrometry (MS) has become a key tool for proteomic analysis and 
has made proteomics a powerful method for the identification, annotation 
and quantitation of proteins in large-scale studies. Over more than a century, 
mass spectrometry has been improving in separating chemical species of 
different mass. The development of electrospray ionization (ESI)7, 8 and 
matrix assisted laser desorption/ionization (MALDI)9 has revolutionized the 
way of protein analysis. These techniques introduced ways to generate ions 
from large, nonvolatile, molecules like proteins and peptides, and to transfer 
them directly into the gas phase for the MS analysis.10 Unknown peptides or 
proteins can be routinely and automatically identified by data-dependent 
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tandem mass spectrometry (MS/MS). Recently described data-independent 
acquisition methods, such as SWATH MS,11 also enables extensive 
proteome coverage in a fast, consistent and accurate manner. It cyclically 
records fragment ion spectra of all precursor ions contained within user-
defined RT-m/z swath throughout the LC run. The resolution or peak 
capacity can then be increased further by coupling the mass spectrometer to 
a liquid chromatography (LC) system. However, the electrospray ionization 
is sensitive to presence of salts and even though LC does help in removing 
contaminants, additional purification and cleaning steps are often necessary.  
The speed, accuracy and a large variety of mass spectrometry tools have 
brought proteomics to a new level, creating great possibilities for research 
applications. The area of proteomics dedicated to post-translational 
modifications (PTMs) is primarily concerned with the study of cell 
signaling and regulation which cannot be directly investigated by the 
genomic tools. The new field of clinical proteomics has emerged aiming at 
the protein profiling in large numbers of samples, and in drug and 
biomarker discovery studies. Biofluids commonly used for such 
investigations poses a great challenge due to their wide dynamic range of 
more than 10 orders of magnitude difference in concentration. Clinically 
relevant molecules are usually present at ng/mL levels and are near or below 
the detection limit of the currently available LC-MS/MS analysis tools.12
Development of such approaches as selected reaction monitoring (SRM) for 
targeted MS measurements has made possible robust and sensitive 
measurements of protein biomarkers. Picotti et al. has shown that LC-SRM-
MS improves the lower detection limit by up to 1000-fold and that the 
method therefore is suitable for the quantification of proteins over a large 
part of the range of cellular and body fluid concentrations.13
In parallel, one of the primary objectives of proteomics has become not only 
protein identification but also quantification of the differences between 
samples. Numerous labeling techniques are available for incorporating 
isotopic or fluorescent groups to the protein or peptide and are usually 
oriented only on the limited number of targets. Stable isotope standards and 
capture by anti-peptide antibodies (SISCAPA)14 combines high sensitivity 
of SRM and high-throughput approaches, enabling rapid detection and 
quantitation of low abundant species in the biofluids.15 Despite the high 
accuracy of these methods there are several obvious drawbacks. The sample 
preparation method is usually complex and involves additional labeling 





number of fractions which can be analyzed is always limited. It is also 
possible to quantify peptides/proteins directly from the mass spectrometry 
signal, so-called label-free quantitation. Even though undersampling in 
complex samples is still a limitation in label-free LC-MS or LC-MS/MS and 
spectral counting approaches, a recent study of Nagaraj et al. achieved 
nearly full coverage of the yeast proteome in a single-shot label-free 
analysis, illustrating these methods also harbor significant promise.16 These 
methods are particularly useful for large clinical studies and time- or space-
resolved proteomics in systems that are not easily or inexpensively labeled. 
Such approaches demand rapid, robust and highly reproducible sample 
preparation methods, preferably automated data analysis procedures and 
benefit from using high resolving-power mass spectrometers. 
Design of experiment 
As proteomic studies are usually complex and require many subsequent 
steps, it is crucial to have a clear overview of the experiment. Scientists 
have long realized the necessity to properly design experiments prior to 
their execution. Even though intuitively basic aspects of experimental 
design such as comparison, controls and repetition have been used since the 
beginning of science, the first formalized methodology for design of 
experiments (DOE) was suggested by Fisher in 1926.17, 18 The aim is to 
design the most meaningful experiment which will provide clear and easily 
interpreted answers to the research question. DOE is a process which 
includes anticipation of the different variables and parameters that would 
influence the outcome of the experiment. From here there are two possible 
ways to go. The most common approach is to define the hypothesis which 
describes the theoretical or expected outcome, for instance the null 
hypothesis stating an absence of an effect, causality or correlation. 
Experiments are then performed to answer whether the hypothesis is true or 
false, or whether the null hypothesis can be rejected. Biomedical research in 
general still rests on this hypothesis-driven methodology, focusing on 
explaining the cause-effect relationship between controlled and observed 
variables. In this case, application of the established principles of DOE 
allows us to determine which number of samples or replicates is needed to 
observe a statistically significant effect, given the expected biological and 
technical sample-to-sample variability. It also informs us on which 
biological or technical controls or references are required. In protein 
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analyses, this implies a targeted approach, focused on small differences or 
changes in a small number of components. 
With the rapid development of “omics” technologies, the amount of data 
that can be produced in a short time has increased tremendously, potentially 
generating large amounts of information. Today we are able to measure the 
expression of thousands of genes or proteins in a single analysis.16 In such 
“omics” contexts, the goals of experimental design are radically different. 
The purpose of the experiment is more often than not to illuminate a 
biological system as completely as possible without knowing a priori which 
ones out of the thousands of analyzed components (transcripts, peptides, 
phosphorlylation sites) are most important. Compared to targeted analyses, 
we often have to sacrifice some analytical sensitivity. On the other hand, the 
data can guide the design further, targeted and more sensitive experiments 
to investigate a particular pathway or reaction in detail. To make an 
analogy, a targeted approach would look closely at the paintings of Vincent 
van Gogh and see only seemingly randomly and crudely applied strokes of 
paint. The “omics” approach is to take a step back and look at the paintings 
from a distance, from which you can see the entire picture with its story, 
composition and rich palette of colors. Similarly data-driven approaches in 
proteomics give an overview of the major characteristics of a biological 
system in a certain state, down to some but not infinitesimal level of 
refinement or detail. One could consider this lowest level of detail the 
“resolution” of the proteomics experiment. Subsequent experiment can of 
course be more targeted, looking into more detail but relinquishing the 
global level of analysis. This is essentially what is meant by data-driven, 
hypothesis generating experiments. 
In a generalized sense, the objective of DOE in data-driven proteomics is to 
maximize the quality as well as quantity of data, such as the number of 
identified proteins, quantified peptides or detected PTMs, obtained from an 
experiment within time and economic constraints, or possibly even 
minimizing time and/or financial costs. There are a number of important 
variables or choices that need to be made for optimizing such experimental 
designs. When working in a purely data-driven mode, generating high-
dimensional data to produce a base for formulating new hypotheses rather 
than answering the existing ones, we need to define the state of the system 
and what biological processes are to be illuminated. What magnitude of 
changes do we expect and on what time scale? This then determines how 





much sample is needed, and how it needs to be prepared. In the time-course 
studies, how do we cultivate and harvest sufficient numbers of synchronized 
cells in a reproducible manner and under carefully controlled conditions 
while allowing sample collection at any given time without disturbing the 
culture(s)?  
If we wish to fractionate the cells into compartments, how many cells are 
needed in the starting material to recover sufficient amount of analyte in 
each fraction? What subcellular or protein fractions should we enrich or 
purify, and how do we best set up the methods for analyzing the proteins or 
peptides using different fractionation techniques? How frequently does the 
system need to be sampled in order to follow rapid or oscillating processes, 
analogously to the Nyquist sampling theorem?19, 20 What methods can be 
used for robust and easily parallelized (high throughput) sample preparation 
required in larger clinical studies?  How do we achieve the best proteome 
coverage with the best possible accuracy and precision in identifying and 
quantifying the proteins? These are some of the most common 
considerations in planning proteomics experiments, and they can all be 
addressed by making conscious, systematic choices where each choice is 
dependent on other parameters. For example, opting for a bioreactor to 
cultivate and sample bacteria under controlled conditions for time-course 
studies, or the use of SDS-PAGE as an extra dimension of protein 
separation for increased proteome coverage for MS/MS-based analysis 
instead of digestion of a total cell extract. 
Sometimes the dynamics of the system or the cellular population or 
subcellular component of most interest are unknown. A small, well-
designed pilot experiment can then be useful in planning larger proteomics 
experiments. Typical parameters that one would determine from a pilot 
experiment are the amount of material needed, the time points to be sampled 
and the reproducibility of the measurements. Note that these may not 
require “omics” technologies – for instance system dynamics can be 
investigated using other, less expensive, readouts, such as microscopy or 
simple biochemical assays. 
In the ideal situation, the data generated by a proteomics experiment would, 
with the proper analysis and interpretation, generate sufficient information 
to formulate single/few gene/protein-pathway hypotheses and a clear 
suggestion how to test these hypotheses. High-dimensional proteomics data, 
e.g. proteins and isoforms with an abundance varying in time and in cellular 
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localization, requires extensive mathematical and statistical analysis, 
including false identification/false discovery rate (FDR) estimation at 
different levels. In addition, as the field and experimental capabilities are 
rapidly growing, not seldom requiring development of new tools for 
automating and accelerating data processing from raw mass spectra to 
biological modeling and visualization (Figure 1). 
When planning a proteomics study, the main question to be answered is 
what we want to achieve by the experiment. If properly posed, it can guide 
the design of the experiment to what cells, tissues or body fluids to use, 
when and how to collect samples, which separation and prefractionation 
techniques to exploit and what statistical and data analysis tools to apply. 
Figure 1. Simplified representation of the Taverna scientific workflow for the data 
processing. The raw ion trap data is converted to mzXML format and searched. Resulting 
library of accurate mass and time tags is then aligned with FT-MS data. Peptide 
identifications are grouped in proteins. For each match the intensities within retention time 
and m/z window are integrated. Final table is passed to Rshell where statistical analysis and 





A typical proteomics experiment 
Most proteomics experiments consist of several stages: cell cultivation 
and/or sample collection, sample preparation, protein and/or peptide 
separation, data acquisition and data analysis. As there are no specific 
amplification techniques analogous to the polymerase chain reaction 
(PCR)21 or sequencing by synthesis,22 it is important to extract proteins 
efficiently, avoiding unnecessary losses during sample collection and 
preparation and rather enrich the sample in proteins of interest. Knowing at 
least approximately the optimal amount of peptides to load on the 
chromatographic column coupled directly to the mass spectrometer and 
estimating the protein or peptide yield, concentration or dilution in each 
step, it is possible to calculate backwards to the minimum appropriate 
amount of starting material required for an experiment. However, there are 
no universal rules on how to know in advance the amount of biological 
material, e.g. plasma volume, numbers of cells or mass required for a 
particular experiment. The choice is most often based on experience with 
similar samples or established by trial-and-error and dependent on which 
instrumentation is to be used for the analysis (different separation methods 
or direct infusion), the method of sample preparation (pre-fractionation or 
the total cell extract) and the nature of the sample (cells, organelles, tissues 
or biological fluid). For example,  when comparing two different pre-
fractionation techniques for increasing proteome coverage, our system for 
SDS-PAGE, separation of proteins does best with ca. 30 µg of protein, 
whereas our larger-volume isoelectric focusing device functions best with 
100-250 µg peptides.23
To illustrate this using a real example, consider the following experiment: 
Bacteria, as most other organisms, are sensitive to environmental changes 
such as oxygen deprivation, high salt concentration or temperature 
alternation. If the temperature is raised quickly, such as would happen 
during high fever, the bacteria will suffer a heat-shock. Using the common 
and well-studied Eschericia coli model because of its simple culturing 
procedure and well-characterized and relatively small genome/proteome 
(~5,000 genes), we can investigate what happens at the proteome level in 
this bacterium during and after heat-shock. To observe these changes, cells 
need to be collected at the same time points from both normal/optimal 
growth conditions as well as at elevated temperature or stress conditions. 
Define time zero as the moment when half of the cell cultures, leaving the 
other half at the 37°C, are moved to a growth chamber set at 42°C (the heat-
shock environment) (Figure 2a). To be extra careful, we can take all the 
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cultures out, before returning them to the growth chambers, to ensure they 
are handled in the same way except for the growth chamber temperature. As 
mentioned above, the culture volume we need to collect at each time point is 
dependent on the amount of protein needed, our estimated recovery during 
sample preparation and the cell density. The amount of protein extractable 
from a single cell obviously depend on the size of the cell. A prokaryote 
such as E. coli is only 0.5-5 µm3 in volume, while human cells range from 
100 to 100,000 µm3.24 It can not be assumed that the cell density or cell 
sizes will be the same in the heat-shocked cultures as in the control cultures 
(in fact, we know it will not be, as 42°C is not optimal for the growth of 
E.coli), so this needs to be taken into consideration when planning the 
experiment. To have a reference and simple readout of the experiment, it is 
useful to control the cell density, which can be seen as  a marker for cell 
“well-being” and also gives an idea of the time scales of the processes 
involved and what time points should be sampled during the experiment. 
Before time “0”, sampling can be done less frequently, as we assume cells 
are growing in the log phase, and a couple of time points are always useful 
to demonstrate that no significant changes, except for the rapid gain of the 
biomass, occur during this time. Even though changes at the protein level, 
essentially integrating gene expression over time (in simple systems), are 
less rapid than changes in gene expression, it is important to arrest cell 
growth and protein synthesis quickly immediately after collection, as the 
cells will otherwise keep growing and dividing, reacting to the new 
environment and leading to unwanted bias in the data. To ensure each 
sample is a “snapshot” of the cells, we quench all the cellular processes at 
the moment of sampling by instant cooling them by adding ice, then 
removing the growth medium and washing the cells in a sterile buffer. 
When working with cells, we have to disrupt the cell wall to release proteins 
and get a high and reproducible yield. Depending on the biological system 
investigated and the compatibility of downstream sample preparation 
methods, we can opt for a mild lysis with detergent-free buffers or a harsher 
mechanical disruption with beads in a high concentration urea or extraction 
in a hot ultrasonic bath with SDS. For a label-free method, or any method 
that does not label the cell already in the culture or includes internal 
standard, the reproducibility of the protein extraction method is of 
paramount importance. Many commercial kits are available for protein 
extraction and each laboratory typically develops their own extraction 
protocols that work well in their lab with the available equipment and 





DNA (an endonuclease). The latter is practical, as the extracts otherwise 
become extremely viscous, making pipetting and further sample preparation 
more difficult and likely less reproducible. 
The “box standard” proteomic approach is bottom-up, operating on peptides 
obtained from protein extracts by proteolysis. Proteolysis by enzymatic 
digestion can be performed in free solution25 as well as in-gel after protein 
separation by electrophoresis26 or on filter27 and is done in a few simple 
steps: reduction of disulfide bonds (cystines), alkylation of cysteins and 
finally enzymatic cleavage of the peptide bond by a more or less specific 
protease (Figure 2b). Even after the inherent sample cleanup during 
extraction and digestion, especially when using in-gel or in-filter digestion, 
the resulting peptide mixture is still too complex for direct analysis by mass 
spectrometry. At least one more separation step at the peptide level is 
required for deep proteome coverage. A comparison between different 
protein and peptide fractionation methods is found in Chapter 1 of this 
thesis. In short, fractionation techniques are based on various 
physicochemical properties and aim to reduce sample complexity and/or 
enrich or deplete certain proteins or peptides and are often combined in 
multidimensional systems, connected off-line or on-line, with a final peptide 
separation by reversed-phase liquid chromatography (RPLC) introducing an 
orthogonal dimension of separation based on the hydrophobicity of the 
peptides.28, 29 Obviously it makes no sense to combine similar separation 
techniques. In practice, most separations are oblique, i.e. not fully 
orthogonal, as fundamental properties such as size or charge always have 
some influence on the separation. The main reason RPLC is used last is that 
the mobile phase is fully compatible with electrospray ionization (or 
conversely, an ideal electrospray solvent still works as a mobile phase in 
RPLC). 
Returning to the experiment, we have sampled the bacterial cultures a 
number of time points in replicate. Even in a simple and limited experiment 
such as this, we will have in the order of 100 samples that need to be 
prepared and analyzed. This is unavoidable if we want to study real 
biological processes, which are always dynamic, and need biological 
replicates to get meaningful results. In practice, this limits the number of 
dimensions of fractionation or separation to one or perhaps two. For E. coli,
we can extract the proteins using a commercial lysis cocktail, such as 
BugBuster® from Novagen, and proceed directly with reduction, alkylation 
and digestion with trypsin. The digests are reasonably compatible with  
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Figure 2. Experiment workflow. Sample collection (a) and sample preparation and mass 
spectrometric analysis (b). E. coli cells are incubated at two different temperature 
conditions (37°C and 42°C) and collected at times “0”, 20, 40, 60 and 120 min after the 
splitting of cell culture. Proteins then extracted and split for SDS-PAGE and in solution 
digestion. SDS-PAGE is cut into 48 equal slices, placed in the 96-well plate and digested in 
gel. Resulting peptides are analyzed with LC-MS/MS. Peptides obtained after in solution 
digestion are analyzed with LC-FTMS. 
RPLC, as long as trap columns are used when loading the sample. Each 
sample is then analyzed by LC-MS, ideally using a high-resolution mass 
spectrometer such as TOF or FTICR. The entire data acquisition workflow 
is described in Chapter 3 of this thesis. Briefly, peptides are quantified 
from their intensity (peak height or peak area) in the LC-MS data while the 
peptide identification can be done on a different type of mass spectrometer, 
such as an ion trap (Figure 2b). This can be in the same sample using 
MS/MS, or, since especially close time points and biological replicates will 
contain many of the same proteins, albeit in different concentration, we can 
generate a small database of peptide identification with RPLC retention 
times and use the accurate mass and time (AMT) approach.30, 31 We can 
even combine multiple ion traps and allow an extra dimension of 
fractionation to improve the identification of low-abundant peptides. In our 


















Figure 3. Protein expression profile of 
chaperon protein DnaK during the heat-
shock. The abundance is calculated 
relative to changes in 30S ribosomal 
protein S1 which is essential for the 
growth33 and has a more stable 
expression. 
and proteins. We identified and quantified 616 proteins including 
Chaperone protein DnaK (UniProt accession number P0A6Y8), 
homologous to eukaryotic Heat-shock protein 70, Hsp70. This protein is 
known to be induced by the heat-shock (hence its name) and was clearly 
expressed more in cells which were shocked at 42°C (Figure 3). This 
finding is consistent with gene expression.32 The protein expression can be 
mapped onto protein interaction or metabolic pathways for biological 
interpretation and hypothesis generation. 
To summarize, proteomics is a powerful tool, both for describing biological 
systems in specific states as well as for quantifying differences between 
states or systems. However, the planning and execution of proteomics 
experiments remain complex and this thesis attempts to illuminate some of 
the most critical aspects of designing such experiments, including sample 
preparation, fractionation and enrichment, and data acquisition, analysis and 
visualization, in fundamental biological and clinical research. 
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ABSTRACT
Multiple fractionation or separation methods are often combined in 
proteomics to improve signal-to-noise and proteome coverage and to reduce 
interference between peptides in quantitative proteomics. Furthermore, a 
given fractionation method provides additional information on the analytes, 
such as molecular weight, hydrophobicity or isoelectric point that can be 
used to improve identification, and to discover protein splice variants or 
large post-translational modifications. Finally we describe a Taverna 
scientific workflow for analysis and comparison between strong cation 
exchange chromatography (SCX), peptide isoelectric focusing (pIEF) and 
SDS-PAGE performed using robust capillary LC and ion trap tandem mass 
spectrometry.  
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INTRODUCTION
Even with the recent improvement in speed and sensitivity of tandem mass 
spectrometry and performance of liquid chromatography systems, loading 
capacity and ion suppression still limit the coverage of complex samples, 
such as in proteomics. Thus, the prefractionation or reduction of complexity 
of samples is still beneficial in most analyses, when sufficient amounts of 
material are available. In general, each fraction contains a “simplified” 
mixture of peptides/proteins enabling identification and possibly 
quantitation of more peptides and proteins, including those of lower 
abundance. At the same time, fractionation adds information about the 
analytes without any additional analytical effort. This information can be 
used together with the tandem mass spectrometry data in the validation of 
peptide-spectrum matches.  
A wide range of fractionation strategies for peptides and proteins are 
generally available, often combined in multidimensional methods or 
systems. Any type of chromatographic separation can be used at the protein 
level, including ion exchange, 1 reversed phase,2 hydrophobic interaction3 or 
size exclusion,4, 5 prior to digestion. Ion exchange chromatography is 
frequently combined with reversed-phase chromatography, also at the 
peptide level, either off-line or on-line in the same column (MudPIT).6
Other popular methods include Gelfree® fractionation system and SDS-
PAGE.7 The last involves protein fractionation according to molecular 
weight, slicing the entire gel lane containing the proteins and then digesting 
the proteins in the gel. Isoelectric focusing of peptides or proteins can be 
done in capillaries,8, 9 segmented tubes,10-12 gels13 or liquid compartments 
connected by a gel.14
In this work we have attempted to compare, with as little bias as possible, 
three very different and commonly used fractionation methods for two very 
different types of samples. We compared SDS-PAGE fractionation at the 
protein level,7 with Off-Gel™ isoelectric focusing, fractionating according 
to their isoelectric point,13 and strong cation exchange (SCX) 
chromatography, separating based on size and charge at a fixed pH,1 both at 
the peptide level. 
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Several previous studies have already been published for comparing these 
and other fractionation methods.15-17 However, the choice of the best 
method likely also depends on the sample. We therefore compared the same 
three methods using exactly the same protocols for two different biological 
samples – an Escherichia coli whole cell lysate and human plasma. The E. 
coli cell lysates are easy to work with and not dominated by a few proteins. 
Human plasma on the other hand, is dominated by a small number of 
proteins, with albumin making up 45-50% of the total protein content, 
immunoglobulin G and transferrin another 8-20% and 3-7% respectively.18
The 20 most abundant proteins constitute more than 99% of the total protein 
content in plasma.18 Both samples are easily obtained in large (even gram) 
quantities, making it possible to use almost any method for fractionation, 
from preparative scale chromatography to microfluidic methods coupled 
directly to the mass spectrometer. 
The three compared methods each contribute information about a different 
peptide or protein property. This information can be used by some 
algorithms and pipelines to validate peptide and/or protein identification and 
remove erroneous identifications. In SDS-PAGE, the position of the protein 
on the gel has direct relationship with its molecular weight. When the 
measured protein molecular weight is compared with that predicted from the 
genome and used for the peptide identification, splicing events or post-
translational processing could be detected. In IEF, the distribution of the 
peptides corresponds to their pI, which can also be predicted, albeit not with 
perfect accuracy. Finally, in SCX, the elution time (i.e. fraction number) 
depends on the size and charge of the peptides at the system pH,19 which 
may also be possible to predict from the peptide sequence. The Trans-
Proteomic Pipeline20 (TPP) already provides a standard score (also known 
as Z-score) for peptides based on their pI, and the same can in principle also 
be used for SCX chromatography. Indeed, the use of pI information to 
decrease the false discovery rate for IEF fractionated samples has been 
already demonstrated by other groups.21, 22 As part of the work presented 
here we also developed a general data analysis method and implemented 
this in a Taverna scientific workflow. The workflow compares multiple 
fractionation methods with respect to peptide and protein coverage while 
also extracting additional information on the peptides and proteins from 
each fractionation method. This information can be used for validation of 
peptide identifications and detection of splicing or post-translational events. 
We used this workflow to perform and visualize the comparison between 
the three different fractionation techniques for the two different types of 
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samples, and briefly discuss the applicability of each method for each type 
of sample.  
MATERIALS AND METHODS
For this study we compared three different separation approaches for two 
types of samples (human plasma and Escherichia coli). Both groups of 
samples were treated similarly to enable comparison between methods to 
determine their suitability for different kinds of samples. 
Sample preparation 
Human plasma from healthy volunteers was collected into BD Vacutainer® 
tubes with 18.0 mg K2:EDTA (K2E, REF 367525, BD Vacutainer Systems, 
Plymouth, UK) and immediately spun down at 1,300×g for 10 minutes at 
21˚C then aliquoted and stored at -80˚C until use.  
Escherichia coli K12 strain MG1655 (ATCC® Number 47076, ATCC, 
Manassas, VA); was grown overnight in 4×25 mL Luria-Bertani (LB) 
medium in 50 mL Falcon tubes. The optical density at 600 nm (OD600) was 
2.1. Then all cells were spun down and the supernatant removed. The pellets 
were resuspended in 10 mL warm (37°C) PBS to pool all cells and gently 
spun down at 194×g at 37°C for 5 min. After the supernatant was removed, 
all pellets were rinsed with 1ml PBS, transferred to a 1.5-mL Eppendorf 
tube and spun down again for 10 min at maximum speed (16,100×g) at 4°C. 
The wet pellet was weighed and 5 mL of the BugBuster® Master Mix 
(Novagen, Merck KGaA, Darmstadt, Germany) was added per gram cell 
paste. Cells were incubated at room temperature on a shaking platform at 
low speed for 20 min. After the insoluble cell debris was removed by 
centrifugation at 16,100×g for 20 min at 4°C, the supernatant was stored at -




Two mg of each sample were digested using trypsin. To each sample DTT 
in 25 mM ammonium bicarbonate (ABC) was added to its final 
concentration 10 mM and incubated for 45 min at 56°C to reduce cystines. 
After alkylation for 1h at room temperature with 25 mM iodoacetomide also 
in 25 mM ABC trypsin (sequencing grade, Promega, Madison, WI) was 
added in the ratio 1:100 (trypsin:sample) and kept for 10 h at 37°C. 
Digestion was quenched with 10% TFA with the final concentration of 
TFA 0.1-1.0%. Resulting samples were desalted using Oasis HLB 
cartridges and aliquoted in 100 and 200 µg for IEF and SCX respectively. 
Desalting and solid phase extraction 
Prior to fractionation both samples were desalted using Oasis HLB 
cartridges (Waters, Milford, MA). Cartridges were first activated with 
methanol and equilibrated with 50% acetonitrile (ACN) in water according 
to the manufacturer’s protocol. The sample was applied and washed 4 times 
with 500 µL water. The peptides were eluted into a fresh Eppendorf tube 
with 800 µL 50% ACN. 
Fractions collected after the separation were desalted with solid-phase 
extraction (SPE) using C18 OMIX tips (Agilent Technologies, Waldbronn, 
Germany). Tips were first wetted with 50% ACN in water, washed and 
equilibrated with water containing 0.1% TFA. Samples were acidified with 
TFA, washed again and eluted with 50 µL 50% aqueous ACN containing 
0.1% TFA.Acetonitrile was evaporated after each cleaning step. 
Strong cation exchange 
SCX was performed on a Dionex UltiMate 3000 (Thermo Fischer 
Scientific, Waltham, MA) at a flow rate of 200 µL/min. Tryptic peptides 
(200 µg) were loaded onto a 100×2.1 mm PolySULFOETHYL A™  
(PolyLC, Columbia, MD) column with 3 µm packing material and eluted 
with a linear gradient using ACN/potassim phosphate buffers (buffer A – 
20% ACN /80% 10 mM potassium phosphate, pH 2.9; buffer B – 20% ACN 
/80% 10 mM potassium phosphate, 500 mM potassium chloride, pH 2.9). 
The elution program was 100% buffer A for 10 min, continued by a short (1 
min) gradient of 0 to 3% of buffer B, followed by a gradient of 3%-15% for 
19 min, a 15%-45% gradient for 15 min and a 45%-100% gradient for 2 
min. At the end of the gradient the column was kept at 100% buffer B for 7 
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min and then for 10 min in buffer A. Flow-through fractions (48 in total) 
were collected into a 96-well plate from 5 to 55 min. Adjacent fractions 
were combined pairwise to obtain 24 fractions and then desalted with SPE 
(described above). 
Isoelectric focusing 
For peptide IEF separations, the Off-Gel Agilent 3100 fractionator (Agilent 
Technologies) was used. A modified method was applied by addition of 1 
M urea to the buffer sample and rehydration buffer, instead of 5% glycerol 
only. Tryptically digested and desalted peptides (100 µg in total) were 
resuspended in a modified IPG buffer that contained 1M urea in addition to 
the 3–10 pH linear IPG buffer (GE Healthcare, Uppsala, Sweden). Sample 
volumes of 150 µL/well were loaded onto a commercially available 24-cm 
IPG strips with a linear 3-10 pH gradient (GE Healthcare) after rehydration 
of the gel for 20 min in 40 µL/well rehydration solution. Cover fluid 
(mineral oil, Agilent Technologies) was applied to both ends of the gel strip. 
The focusing method OG24PE01, as supplied by the manufacturer, was 
used for 24-well fractionations. Fractions were recovered in separate 
Eppendorf tubes, cleaned by SPE as described above and store at -80°C till 
use.
SDS-PAGE and in-gel digestion 
Protein concentration was measured by the bicinchoninic acid (BCA) 
protein assay kit (Thermo Fischer Scientific) and 30 µg of proteins per 
sample was loaded on a 1-mm 10-well 4-12% NuPAGE® Bis-Tris gel 
(Invitrogen, Carlsbad, CA). Proteins were separated in the gel for 1 h at 180 
V, after which the gel was stained in NuPAGE® Colloidal Blue (Invitrogen) 
overnight at room temperature and destained with milli-Q water until the 
background was transparent. 
The gel lane with separated proteins was cut into 48 identical 1.5×5-mm 
slices using a MEE1.5-5-48 disposable gel cutter (Gel Company Inc., San 
Francisco, CA). Each gel piece was placed into one well in a 96-well 
polypropylene PCR plate (Greiner Bio-One, Frickenhausen Germany). 
Destaining of the gel pieces, DTT reduction and IAA alkylation were 
performed according the previously published protocol.23 In-gel tryptic 
digestion was performed in 30 µL of 25 mM ABC containing 5 ng/µL 
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trypsin (sequencing grade, Promega, Madison, WI) for 6 h at 37°C. The 
resulting peptides were TFA-extracted according to the previously 
described protocol.23 The extracts were pooled pairwise to obtain 24 total 
fractions as for SCX. 
LC-MS/MS analysis 
Prior to LC-MS/MS analysis all samples were dried down and reconstituted 
in 25 µL 0.1% TFA. The analysis was performed using a splitless NanoLC-
Ultra 2D plus (Eksigent, Dublin, CA) for parallel ultra-high pressure liquid 
chromatography (UHPLC) with an additional loading pump for fast sample 
loading and desalting. The UHPLC system was configured with 300 µm-i.d. 
5-mm PepMap C18 trap columns (Thermo Fischer Scientific) and 15-cm 
300 µm-i.d. ChromXP C18 columns (Eksigent). Peptides were separated by 
a 45-minute linear gradient from 4 to 33% acetonitrile in 0.05% formic acid 
with 4 µL/min flow rate. The UHPLC system was coupled on-line to an 
amaZon ETD speed high-capacity 3D ion trap with CaptiveSpray source 
(Bruker Daltonics, Bremen, Germany). After each MS scan, up to ten 
abundant multiply charged species in the m/z 300-1300 range were 
automatically selected for MS/MS but excluded for one minute after having 
been selected twice. The UHPLC system was controlled using HyStar 3.4 
with a plug-in from Eksigent and the amaZon ion trap by trapControl 7.0, 
all from Bruker. 
Data analysis
All acquired tandem mass spectrometry data were processed in one batch 
using the Taverna workbench.24 Taverna can invoke a number of services, 
including local Java Beanshell scripts, R (using an R server) and a wide 
range of Web services, enabling combination of sequence database search, 
analysis and visualization in a single workflow. Built-in tools for parsing 
XML- files simplify information retrieval andlarge datasets can be remotely 
processed on a grid or cloud using the Taverna Engine.25 The workflow 
used here converts raw data to mzXML26 using compassXport 3.0 (Bruker) 
and passes this, along with the sequence database and search parameters to 
X!Tandem20, 27 in the TPP.20 The X!Tandem scores are converted to 
pepXML,20 modelled and converted to probabilities for each peptide-
spectrum match by PeptideProphet.28 The X!Tandem search was here done 
against the UniProt human reference proteome set (2012_02, canonical 
sequences only) and the UniProt Escherichia coli reference set (2010_01) 
with the monoisotopic mass error (±0.5 Da), carbamidomethylation as fixed 
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modification, the k-score plug-in20 and allowing for isotope error. After 
PeptideProphet analysis, the resulting lists of peptide/protein identifications 
with 0.95 probability cut-off (<1% FDR) were analyzed and compared in 
the Rshell script in the same workflow. For each peptide within one IEF 
fraction, pI values predicted by attached function in TPP (based on pK 
values from Bjellqvist et al.29) were extracted and the pI Z-scores were 
calculated as a distance in standard deviation from the mean. To compare 
the pI of true and false matches, a search was also done against a decoy 
database generated by randomizing the E. coli database with make_random 
(http://www.ms-utils.org/make_random.html). For SDS-PAGE, the protein 
molecular weight was calculated from the sequences downloaded from the 
UniProt website directly in Taverna workflow as these are not kept in the 
pepXML results. The entire processing workflow is available in 
myExperiment (http://www.myexperiment.org/workflows/3486.html). 
RESULTS
In this work we compared SDS-PAGE, SCX and IEF separation strategies 
for two different types of samples. For both samples the highest proteome 
coverage we observed with SCX (Figure 1.1) identifying 1,645 peptides in 
plasma and 6,731 peptides in E. coli. While the number of protein 
identifications for the E. coli sample, was approximately the same with the 
three methods, the number of identified peptides varied from 4,221 for IEF 
to 6,231 and 6,731 for SDS-PAGE and SCX respectively. For the plasma 
sample, SCX was clearly better compared to 1,015 peptides identified with 
SDS-PAGE and 831 with IEF. In the recent work of Hassan et al. 30 SCX 
was also demonstrated to be better than IEF, as measured by the number of 
identified peptides. When comparing the number of identified proteins, 
SDS-PAGE gave the lowest coverage for plasma, similarly to a previous 
comparison using HeLa cells.31
To define the quality of the separation we looked on the distribution of the 
number of peptides identified per fraction (Figure 1.2). When separated with 
SCX, most peptides were found in one fraction. For IEF, the majority of 
peptides is still determined only in one fraction, however the number of  
1































Figure 1.1. Comparison of the number of unique peptide identifications from SDS-PAGE, 
SCX and IEF datasets for human plasma (a) and E. coli (b).
Figure 1.2. Pie charts illustrating the percentage of peptides identified in one or more 
fractions after separation of human plasma by IEF (a) or SCX (b). During the SCX 
chromatography 48 fractions from 65 min gradient were collected and every two 
consecutive ones pooled together.
peptides found in two and more fractions is much higher compared to those for 
SCX. Presented in Figure 1.2 pie charts illurate the peptide distribution for human 
plasma sample. For E. coli the observation is consistent (data not presented). 
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SDS-PAGE, on the other hand, provides direct information about the 
proteins rather than the peptides. Predicted, based on the sequence, protein 
molecular weight plotted against its location on gel (fraction number) shows  
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Figure 1.3. Fractionation of human 
plasma and E. coli peptides by isoelectric 
focusing. The photograph shows the pH 
indicator from pH ~3 to pH ~10 in the 
fractions of plasma (top) and E. coli
(bottom). The pH gradient appears 
reproducible and independent from the 
sample. The fraction yielding the largest 
number of spectrum matches for a 
peptide can be plotted against the 
predicted pI for the peptide (here 
showing only the IEF fractions in E.
coli). The mean pI of the peptides in 
each fraction is marked with red bars. 
The pI information can be used to weed 
out false identifications. The box plot (b) 
illustrates the distribution of pI Z-scores 
with putatively correct matches in white 
and decoy matches in grey. 
A further motivation behind this study was to produce, from the same 
samples, similar datasets using the three different peptide and protein 
fractionation techniques to illustrate the value of the additional information 
on the analytes that can be automatically obtained from a particular method. 
Using a pH indicator, we observed that the peptides in IEF separate more or 
less linearly in the pH gradient independent of the nature of the sample 
(Figure 1.3a, top). Thus the calculated pI can be plotted against the actual 
fraction number and eventual outliers would most likely be false 
identifications (Figure 1.3a, bottom). Predicted pI appear to change in more 
discrete steps compared to the smooth transitions of the pI indicator. 
Another way to represent this information is to calculate pI Z-score and 
visualize their distribution for each fraction separately using histogram or 
box-plot (Figure 1.3b). The decoys have a wide distribution in Z-score (the 
unit determined by the standard deviation in predicted pI of the matches 
from the correct database) and as expected with bias towards higher pI for 
fractions of low pI and towards lower pI for fractions of high pI, whereas 
the correct identifications are focused near the average pI of all peptides 
identified in the fraction. 
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DISCUSSION 
The wide range of available fractionation techniques makes it challenging to 
choose the one best suited for a particular sample or biological research 
question. We performed in this work comparison of the described above 
techniques at the level of proteins (SDS-PAGE) and peptides (IEF and 
SCX). The major challenge in setting up such a study is to make the 
comparison “fair”, given the differences in scale and practical 
implementation of the techniques, i.e. sensitivity levels, system 
volumes/flow rates and fraction collection. It is especially difficult to use 
the same amount of starting material for each method without diluting the 
sample or overloading one or more of the systems. In the case of SDS-
PAGE, the maximum amount of protein that can be applied on the standard, 
commercially available, gel without overloading is around 30 µg. For the 
IEF and SCX methods, the equivalent amount of peptides would be too low 
due to the minimal volumes involved. The work of Hubner et al. 31
demonstrated that the best separation with IEF could be achieved with 50 
µg material, while the maximum number of protein identifications was 
achieved with 250 µg. From our experience, the optimal condition for Off-









































































































































































Figure 1.4. Protein molecular weight 
distribution against fraction number in 
E. coli sample (left). Median 
molecular weight per fraction is marked 
in red. SDS-PAGE of 30 µg of E. coli
sample (a) and molecular weight marker 
(b) on the right. Alkyl hydroperoxide 
reductase subunit C (UniProt accession 
number P0AE08) is marked with an 
arrow.
a clear correlation (Figure 1.4). However, a number of outliers can still be 
identified for closer examination or discarding as false discoveries. As an 
example, the 20 kDa Alkyl hydroperoxide reductase subunit C (UniProt 
accession number P0AE08), in native conditions disulfide-linked 
homodimer, was observed at ~40 kDa (Figure 1.4, arrow).
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has been obtained when loading 100 µg. Even though SCX gave reasonable 
separation when loaded 100 µg of material, the system was far from its 
maximum loading capacity, leading us to increase the amount of proteins 
injected to limit sample dilution. For this reason we compromised and 
loaded different amounts to allow each fractionation technique to operate 
near its maximum capacity, taking into account the significant dilution in 
the IEF and SCX as compared to SDS-PAGE. Robustness and stability of 
the liquid-chromatography-mass spectrometry analysis is also important for 
the method comparisons in absence of internal standards or labels. To 
balance sensitivity and robustness, the choice was made to use the new 
CaptiveSpray (Bruker) source, accommodating higher flow rates and 
therefore more robust chromatography than the more sensitive but less 
stable nanoelectrospray. 
One would expect SDS-PAGE to be a good choice for samples dominated 
by a small number of abundant proteins, such as plasma, as these abundant 
proteins can be confined to a few bands or fractions. In contrast, when 
performing the fractionation at the peptide level, peptides from the abundant 
proteins will be present in most if not all fractions. However, in this 
comparison, we demonstrated that SCX was clearly better in both peptide 
and protein yield. This proves that the loading capacity can be more 
important than the separation method or whether the fractionation is done at 
the protein or peptide level. The IEF approach gave the smallest number of 
identifications and showed the largest overlap with the other two techniques 
for both samples. Even though the work of Hubner et al. 31 showed that Off-
Gel IEF gives higher number of protein identifications compared to SDS-
PAGE in human cell lines, other recent work comparing SDS-PAGE, SCX, 
IEF and organelle fractionation have showed the opposite.32 For the IEF 
system it is known that near the edges of the gel (at pH 3 and pH 10) it is 
common to see diffuse bands if the gel is stained, indicating less sharp 
separation. Consequently, peptides can be found in more than one fraction 
near the edges, increasing the redundancy of the data and reducing the 
number of different peptides that can be identified. During the SCX 
chromatography, fractions were collected every 60 seconds and subsequent 
fractions were pooled for the analysis to keep the number of fractions 
similar to those obtained with IEF and mass spectrometry analysis time 
constant throughout the whole experiment. The number of collected 
fractions with SCX is determined by the fraction collection method, which 
can easily be adjusted to any number, as long as the vials or wells can hold 
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the volume and there are enough physical vials or wells in the fraction 
collector. Similarly for SDS-PAGE, any reasonable number of pieces can be 
cut, as long as the slices are not too thin to handle in a practical manner. 
Generally, more fractions lead to wider proteome coverage if the mass 
spectrometry time per fraction is constant. As the numbers of SCX fractions 
and gel slices are easy to vary, the defining factor for the number of 
collected fractions was the IEF system. For SDS-PAGE, we used an already 
existing and commercially available cutter enabling slicing the gel into 48 
equal slices at once. Similarly, we used an existing method for collecting 48 
SCX fraction and then pool the adjacent ones to obtain 24 total fractions for 
each separation method. Most peptides identified with SCX were found in a 
single fraction, showing that peptides elute in narrow peaks (maximum 2 
minutes in a 65-minute gradient). Compared to the studies conducted by 
Slebos et al. 17 and Elschenbroich et al. 33 demonstrating that IEF is superior 
to SCX in resolution, we used longer and better analytical column for SCX, 
with smaller bead size. Not surprisingly, in our experimental set-up, SCX 
had better resolution than IEF, defined as peptide overlap between fractions. 
The fractionation settings and the design of the comparison have more 
influence on the result than the nature of the sample. 
For any scheme that uses information from the fractionation prior to the 
chromatographic separation on-line with the tandem mass spectrometer it is 
crucial that this information is preserved throughout the data analysis. This 
is easily accomplished by a systematic naming of files or by loading 
fractions in sequence into a microtiter plate. From each dataset, specific 
protein or peptide information could be extracted and used for filtering out 
spurious identifications. The theoretical model used for pI calculation is 
based on the peptide sequence and does not take influences of nearby 
residues into account, leading to a discrete rather than smooth distribution of 
pI in the IEF-separated samples. However, this information is used in the 
calculation of pI Z-scores for each peptide-spectrum match, assuming they 
derive from a fraction with a narrow pI distribution, and is already 
implemented in the TPP. Random, false (decoy) peptide-spectrum-matches 
can derive from peptides of any pI therefore having a wide span, whereas 
the correct identifications are concentrated around 0. For a perfect Gaussian 
distribution, the lower and upper quartiles, i.e. the “box”, would be between 
Z-score -0.68 and 0.68. In the pI box plots in Figure 1.3b, the lower and 
upper quartiles of the putatively correct peptide identifications span a 
slightly smaller interval. This is likely due to a number of outliers caused by 
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Although some success has been reported in the prediction of peptide 
retention times in SCX34, 35, this has so far only been achieved with 
machine-learning techniques such as artificial neural networks, requiring 
tens or hundreds of thousands of peptide identifications to train the model. 
This makes the approach feasible only when very large collections of 
datasets are available. A simpler model could be plugged into the workflow 
as available on myExperiment. Since both SCX and IEF are primarily based 
on charge (SCX on the charge at a particular pH) it may be tempting to use 
a similar model for SCX prediction as for pI prediction in IEF. However, for 
the datasets used in this work, this did not produce a useful model. 
peptide level, without influencing the probabilities assigned to the peptide-
spectrum matches. 
very abundant peptides being identified in many fractions and differences 
between calculated and real (experimental) pI. 
Protein information derived from SDS-PAGE can indirectly indicate 
whether peptide identifications correspond to a protein that is likely to be 
present in the fraction from which the spectrum was acquired. However, as 
there are many reasons why the calculated and measured protein molecular 
weights may differ significantly, it is probably more sensible to use the 
protein level information to learn something about the proteins. Proteins 
located far above a curve fitted to the predicted molecular weights are larger 
than predicted (Figure 1.4), which might be due to an incomplete sequence 
in the database, a large post-translational modification or a covalent protein 
complex. Hits below the curve indicate that the observed protein is only part 
of the predicted (database) protein sequence. If both explanations are 
implausible and the number of confident peptide-spectrum matches for a 
protein is small (given the total number of spectra acquired), the protein 
identification is likely incorrect. This assumption is supported by the 
relatively low probabilities for the peptide-spectrum matches for these 
proteins. In prokaryotic organisms, there is little post-transcriptional 
activity, such as splicing, that leads to multiple protein isoforms from the 
same gene or entry in the searched FASTA file. There are also fewer post-
translational events decorating proteins with adducts large enough to be 
noticeable by SDS-PAGE. Therefore, the outliers are most likely false 
identifications, and their number is very small compared to those in 
eukaryotic samples. A few exceptions, such as covalent complexes, can still 
be identified though, as shown in Figure 1.4. Using the SDS-PAGE 
information, false positives can be weeded out at the protein- rather than the 
1
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CONCLUSIONS
In shotgun proteomics, good coverage of complex samples still requires 
more than one dimension of fractionation or separation. However, not all 
separation methods are equally suitable for all types of samples and research 
questions. Here we compared three of the most commonly used techniques, 
SDS-PAGE, SCX and IEF, for two different and “typical” samples. The 
fractionation methods are based on different physicochemical properties and 
were performed at different levels – at the protein level with SDS-PAGE 
and at the peptide level with SCX and IEF. When comparing such different 
separation techniques, it is difficult to make a “fair” comparison. We kept 
the final number of fractions collected equal and the total mass spectrometry 
analysis time constant, but decided to compromise on the amount of protein 
used, performing the fractionation near the optimal conditions/highest 
capacity of each method. The number of collected fractions and MS 
instrument time were kept the same for the comparisons, even though the 
SDS-PAGE and SCX would likely have performed better if more fractions 
had been collected. Under the studied conditions, IEF showed the lowest 
coverage for both samples, which may be partly due to the dilution 
occurring during the run but also to suboptimal number of fractions in IEF. 
The extracted pI information gives an easily implemented method to filter 
out false peptide-spectrum matches. The SDS-PAGE approach resulted in 
better coverage of the proteome, while also providing molecular weight 
information on the proteins. We compromised the resolving power of the 
gel by pooling consecutive pairs of gel slices to keep the total number of 
fractions the same as for the IEF. There is no strict reason to believe that 
combining adjacent fractions is the most optimal way to reduce the number 
of fractions. By pooling two neighbouring fractions where most likely 
similar proteins are dominant, there will be suppression of the less 
represented ones. It is possible that it would be better to combine gel slices 
containing large and small proteins, even though the results would be more 
difficult to interpret manually. 
Strong cation exchange provided the best coverage of both peptides 
(especially for E. coli) and proteins (particularly for plasma). The 
information of SCX retention times which could be used to improve 
sensitivity and lower the false discovery rate was not implemented. 
Although SCX is a very efficient separation technique for peptides and 
orthogonal to reversed-phase, it is most likely that it was the larger amount 
of sample that could be loaded on the SCX column, compared to the SDS-
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PAGE and IEF that contributed the most to the higher number of 
identifications. 
The data analysis, from raw data to the graphs as they appear in the paper, 
could be performed entirely within one Taverna workflow, facilitating 
sharing not only raw data but also executable workflows. This allows other 
researchers to reproduce the analysis while varying input parameters or 
apply the same analysis workflow on their own data. Additionally, separate 
components of the workflow could be reused in different analyses or 
adopted for other tasks. The workflow executed local commands and took 
the data through the Trans-Proteomic Pipeline interfacing data analysis of 
three separate datasets in parallel using one parameter and one FASTA files 
piped to different processes assuring exactly the same conditions for each 
search. This workflow also fetched information from on-line databases, 
performed statistical analyses in R and plotted the results. 
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ABSTRACT
Blood plasma is a highly complex mixture of proteins, metabolites and 
lipids, and a rich source of potential biomarkers for a range of diseases and 
conditions. The wide range in protein abundance poses a tremendous 
challenge for plasma proteomics. However, as a relatively small number of 
proteins makes up most of the total protein pool, the concentration range can 
be compressed by depletion of abundant proteins, such as albumin. 
Although many commercial solutions are available for depleting one or 
more abundant proteins, general enrichment of low-abundant proteins or 
specific enrichment of selected peptides after enzymatic digestion, none of 
these solutions is simultaneously robust, high-throughput, inexpensive and 
suitable for label-free analysis. We have explored a method for binary 
partition with partial depletion of albumin for quantitative plasma 
proteomics based on semi-selective precipitation with acetonitrile at 
different pHs. The method is simple, reproducible and easily parallelised 
(high throughput), and may be well suited to fractionate plasma proteins for 
label-free quantitative proteomics. 
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INTRODUCTION
Plasma contains carbohydrates, lipids, salts, vitamins, amino acids, nucleic 
acids, hormones and around 75 mg/mL protein.1 The carrier-protein albumin 
dominates with 45-50% of the total protein concentration, while 
immunoglobulin G and transferrin contribute 8-20% and 3-7%, 
respectively.2 These and other highly abundant, large proteins mask less 
abundant ones by decreasing their relative concentration and through effects 
such as ion suppression in electrospray ionization mass spectrometry. 
Although changes in the abundant proteins may also be indicative of the 
physiological status of the organism,3 low-abundant proteins, for instance 
from tissue leakage, may mark an early state of a disease such as cancer.4, 5 
Although plasma is easily sampled, the concentration range of proteins, 
spanning from picogram to microgram per millilitre, is a major challenge in 
clinical proteomics. 
Numerous techniques have been suggested and employed to reduce the 
complexity of the plasma proteome, including depletion of abundant 
proteins,6 nonspecific enrichment of low-abundant proteins via 
combinatorial peptide libraries7 and specific enrichment of targeted peptides 
after enzymatic digestion.8 Complexity reduction can be performed by 
classical methods such as centrifugation or extraction with organic solvents9 
or by immunodepletion10. A range of depletion columns, spin cartridges and 
affinity capture beads for removal of albumin, IgG11 and many other 
abundant proteins are commercially available. Several of these commercial 
kits have previously been compared by Chromy et al.12 and Björhall et al.13 
for their utility in plasma proteomics. Immunoaffinity is efficient in 
depleting selected, abundant proteins, but in significantly reducing the 
concentration range of proteins in plasma, many different antibodies are 
needed. As the immunoaffinity depletion is carried out under native 
conditions, other, less abundant proteins may still be bound to one of the 
abundant proteins being depleted, for instance albumin in plasma. Typically, 
commercial affinity columns use avian IgY antibodies against the most 
abundant (“top”) plasma proteins and remove from 50% (anti-albumin only) 
to 99% (top-20) of total plasma protein. In theory, assuming a 100% 
recovery, low abundance proteins would then be enriched by a factor 2 to 
100, respectively. However, both reproducibly manufacturing and applying 
columns with a large number of different antibodies is not trivial. For 
instance, we have previously observed a significant column-to-column 
variation in commercial affinity depletion columns (unpublished results). 
Although this may not be a serious problem in a general exploration of the 
2
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plasma proteome or in studies where proteins have been isotopically (or 
otherwise) labelled prior to the depletion/enrichment step, poor 
reproducibility obviously poses a serious problem for label-free studies.
Many of the abundant proteins in plasma have molecular weights exceeding 
60 kDa (e.g. albumin, transferrin, fibrinogen, IgA, α-2-antitrypsin, 
apolipoproteins, and acid-1-glycoprotein). A simple and semi-selective 
depletion of many of these large and highly abundant plasma proteins is 
possible by precipitation using organic solvents such as acetonitrile and this 
has indeed been demonstrated in plasma and serum from several species 
with reproducible results.14-18 This procedure results in a separation, wherein 
most of the more soluble low molecular weight proteins are left in the 
supernatant and the larger proteins precipitate. Acetonitrile has also been 
shown to release albumin-bound proteins, which could be potential 
biomarkers.5 Protein solubility is also affected by pH, ionic strength and 
temperature,19 and by adjusting one or more of these parameters, the 
precipitation may be optimized to efficiently remove as much of the 
abundant proteins, such as albumin, as possible in a single step, while 
maintaining low-abundant proteins in solution. Alternatively, several 
precipitation steps can be combined for a more efficient depletion of 
abundant proteins and increased recovery of low-abundant proteins. Semi-
selective precipitation may also be tuned to partition the proteome in two or 
more complementary fractions with limited overlaps for increased combined 
coverage of the proteome. In this work we focused on the effect of pH on 
the plasma depletion by acetonitrile and its suitability for clinical 
applications. Such a simple precipitation procedure is attractive for large 
scale studies as they are inexpensive, scalable, easy to parallelize, 
potentially robust and reproducible and not dependent on expensive affinity 
separations with concomitant batch-to-batch or column-to-column variation, 
problematic for label-free methods.  
MATERIALS AND METHODS 
Sample preparation and organic precipitation 
Human plasma from healthy volunteers was collected into BD Vacutainer® 
tubes with 18.0 mg K2 EDTA (K2E, REF 367525, BD Vacutainer Systems, 
Plymouth, UK) and immediately spun down at 1,300 g for 10 minutes at 
21°C, and 50 µl aliquotes were stored at -80°C until use. Samples were 
×
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thawed at 4°C and then centrifuged at 16,100×g at 4°C for 1 minute. The pH 
was adjusted in three identical aliquots to 5.0, 7.0 and 9.0 by adding acetic 
acid and ammonium hydroxide directly to the sample. Three other aliquots 
were diluted 1:10 (v:v) with 100 mM ammonium acetate buffer with 
corresponding pH’s to investigate the effect of protein concentration. For 
protein precipitation, acetonitrile was mixed with the samples in 1:1 (v:v) 
ratio and the samples were vortexed three times at 1,000 rpm for 5 s, and 
then incubated for 10 minutes in an ultrasonic bath at room temperature. 
Vortexing and sonication steps were repeated twice before the samples were 
centrifuged at 16,100×g at 4°C for 10 minutes. The supernatants after 
precipitation were collected in fresh Eppendorf tubes and both the pellets 
and the supernatants were lyophilized. The precipitates were vigorously 
vortexed and sonicated in 100 µl BugBuster Master Mix (Novagen, Merck 
KGaA, Germany) for pellets and 30 µl for supernatants. The pellet 
precipitates were resuspended in a Bullet Blender (Next Advance Inc., 
Averill Park, NY) with 0.1 mm glass beads which were then removed by 
centrifugation through 30 µm pore size micro-spin columns (Thermo Fisher 
Scientific, Waltham, MA) at the lowest speed. The protein concentration 
was then defined using a bicinchoninic acid (BCA) protein assay kit 
(Thermo Fisher Scientific). This protein extraction reagent has been 
developed for the lysis and protein solubilisation from bacteria, but is 
routinely used in our laboratory and directly compatible with BCA analysis, 
SDS-PAGE, tryptic digestion and samples are easily cleaned up for analysis 
by liquid chromatography-mass spectrometry (LC-MS). 
SDS-PAGE and in-solution digestion 
Thirty micrograms of protein (BCA) per sample were loaded on a 1-mm 10-
well 4-12% NuPAGE® Bis-Tris gel (Invitrogen, Carlsbad, CA). All samples 
were diluted in 2X NuPAGE® Sample Buffer (Invitrogen). Proteins were 
separated in the gel for 1 h at 180 V. The gel was stained in NuPAGE® 
Colloidal Blue (Invitrogen) overnight at room temperature and distained 
with milli-Q water until the background was transparent. 
For in-solution tryptic digestion, 20 µg of each sample was used. The 
digestion was performed after DTT reduction (10 mM, 56°C for 45 min) and 
IAA alkylation (25 mM, 1 h in the dark at room temperature) in 25 mM 
ABC with protein to trypsin ratio 20:1 for 12 h at 37°C. The reaction was 
then quenched with 5 µL of 10% TFA. The samples were stored at -35 °C 
until analysis. 
2
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Liquid chromatography-mass spectrometry 
Peptides derived from all protein digests were separated by splitless parallel 
reversed phase C18 NanoLC-Ultra 2D plus (Eksigent, Dublin, CA) ultra-
high pressure liquid chromatography (PepMap trap columns C18 5-mm, 300 
µm-i.d., Dionex Sunnyvale CA; ChromXP analytical C18 columns 15-cm, 
300 µm-i.d., Eksigent) with an additional loading pump for fast sample 
loading and desalting. Samples were analyzed for 120 min using a linear 
gradient from 4 to 33% acetonitrile in 0.05% formic acid with flow rate 2 
µl/min. The MS and MS/MS (CID-only) spectra were recorded on an 
amaZon ETD high-capacity 3D ion trap with CaptiveSpray source (Bruker 
Daltonics, Bremen, Germany). The ten most abundant multiply charged 
species in the m/z range 300-1300 were automatically selected for MS/MS 
with one minute dynamic exclusion after having been selected twice. 
Data analysis
The complete experiment was analyzed in a single Taverna scientific 
workflow 20 (Figures 2.1 and 2.2) with all external software installed in their 
default locations. For each sample the raw LC-MS/MS files were first 
converted to mzXML 21 using compassXport 3.0.5 (Bruker). The mzXML 
files were then processed as in the open source Trans-Proteomic Pipeline 
(TPP) 22 using both the X!Tandem 22, 23 database search engine and the 
SpectraST spectral library search. With X!Tandem we used the UniProt 
human reference proteome set (2012-02-05, canonical sequences only), 
carbamidomethylation as the only and fixed modification, the k-score plug-
in 22 and a monoisotopic mass error ±0.5 Da, including also the first and 
second isotopic peaks. For SpectraST, the NIST human spectral library from 
2011-05-26 was searched with default settings except for 
carbamidomethylation (“CAM”) of cysteines. All search results (in 
pepXML22) were analyzed by PeptideProphet, 24 then refined and combined 
by InterProphet. Peptide-spectrum matches with a PeptideProphet 
probability p≥0.95 corresponding to approximately a 1% false discovery 
rate (FDR) were included in the analysis. For each protein sequence in the 
FASTA file, a BeanShell component in the comparison workflow (Figure 
2.2) calculated molecular weight using average masses of amino acids, 
GRAVY score (using amino acid hydrophathy information from Kyte and 
Doolittle 25) and pI (using pK values from Bjellqvist et al. 26). The protein 
spectral counts (number of peptide-spectrum matches per protein) in the 
different fractions were then compared with respect to this information and 
visualized using an Rshell. Consortium 
(http://proteomecentral.proteomexchange.org) via the PRIDE partner 
 
Figure 2.1 (left). Taverna scientific 
workflow for the proteomics data 
processing based on the TPP. The raw 
data is converted to the mzXML format 
by CompassXport and each file is then 
separately searched by X!Tandem and 
SpectraST. Only peptides with 
PeptideProphet probabilities ≥95% were 
taken for the further analysis. Separate 
search results were combined by 
InterProphet. The workflow allows 
parallel sample processing.
Figure 2.2 (below). Taverna workflow 
to produce a Venn diagram and charts of 
spectral counts as function of protein 
molecular weight, pI and GRAVY score 
as seen in Figures 2.4 and 2.5. All inputs 
are provided from the outputs of the 
workflow in Figure 2.1 and the two 
workflows may be combined into a 
single, complete workflow. 
 
repository 27 with the dataset identifier PXD000042. The full workflow is 
freely available via www.myExperiment.org (“Plasma Precipitation 
Analysis”). 
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RESULTS AND DISCUSSION 
The method for protein fractionation explored here was designed to partition 
the proteins in the sample, reducing the relative abundance of the 
dominating proteins, and if possible simultaneously remove contaminants 
that might interfere with protein quantitation and biomarker detection in 
body fluids such as plasma. However, at high protein concentrations, such 
as in plasma, there is always a high risk of co-precipitating otherwise 
soluble proteins. Experimentally, we indeed found the preparation of diluted 
samples to be more robust, less time-consuming and the results were highly 
reproducible (Figure 2.3). This method therefore could be more easily 
applied in larger studies. The fractionation of proteins in plasma by 
acetonitrile is expected to be correlated with the molecular weight and 
hydrophobicity (at a given pH) of the proteins.28 It was possible to influence 
the solubility of different plasma proteins by alternating the pH of the 
buffer. For example, proteins with pI 5-6 such as albumin could be expected 
to readily precipitate at a pH of 5 or 7. Pellets obtained at pH 5 or 7 were 
relatively easy to resuspend, but precipitates at pH 9 were very hard to 
dissolve and required additional use of ultrasonication. The reproducibility 
of protein extraction from pH 9 pellets was also poor, with notable changes 
in the abundance distribution of the proteins. Plasma pH in the sample 
usually varies between 7.5 and 8.5 and not surprisingly its precipitation 
profile is most similar to pH 9 where the pellet fraction is not much enriched 
and the supernatant is still highly dominated by albumin (data not shown). 
The combination of X!Tandem and SpectraST identified 8,418 spectra (672 
unique peptides) in the LC-MS/MS analysis of raw plasma, 6,751 spectra 
(568 unique peptides) in pellet fraction and 8,799 spectra (463 unique 
peptides) in the supernatant. As expected, the largest difference, or smallest 
overlap, was observed between the precipitate and the supernatant (Figure 
2.4). The total proteome coverage discovered in pellet and supernatant 
fractions was 25% higher compared to crude plasma. A few peptides and 
proteins were only identified in the raw plasma and not in either the pellet or 
the supernatant fraction. However, relative spectral counts clearly show that 
most of the abundant proteins precipitate at pH 5 and remain in the pellet, 
while small proteins are enriched in the supernatant fraction (Figure 2.5a). 
Examples of such small proteins include several apolipoproteins (e.g. A1, 
A2, A4, C1 and C3) as previously shown by Anderson and Hunter.29 Some 
mid-range (40-60 kDa) molecular weight proteins also increased in relative 
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Figure 2.3. Representative SDS-PAGE gels illustrating the reproducibility of fractionation 
by acetonitrile precipitation at pH 5 of 20 µg human plasma protein from the same (a) and 
different (b) healthy volunteers. The pH of crude plasma samples was adjusted by adding 
100 mM ammonium acetate buffer of corresponding pH in a 1:10 ratio and then 
precipitated with an equal volume of acetonitrile. M1 and M2 – plasma from male 
volunteers, F1 and F2 – plasma from female volunteers. 
abundance in the supernatant. The spectral counts for proteins between 60 
and 80 kDa are primarily due to albumin (90% in the raw plasma). The 
fraction of identified spectra assigned to albumin peptides in the entire raw 
plasma dataset was close to 60%. In the supernatant sample, only 5% of the 
identified spectra were from albumin peptides, indicating a depletion of 
~90%. Also a number of other large and highly abundant proteins, such as 
α-2-macroglobulin and complement C3, were found to be significantly 
depleted. The relative abundance of albumin in the pellet fraction was 
approximately the same as for crude plasma. 
The protein pI can be used as an additional criterion for fraction comparison 
and method evaluation (Figure 2.5b). Proteins are known to precipitate at 
the pH close to their pI values, and therefore most proteins including 
albumin were expected to precipitate at pH 5. However, more proteins with 
pI 5.0-5.5 were identified in the supernatant fraction and very few with pI 
6.0-6.5. Interestingly, despite the peaks at pI 6.5-7.0, 8.0-8.5 and 9.0-9.5 
there were only minor differences between the precipitates generated at 
different pH. The histogram for raw plasma showed a similar distribution to 




































































































































Figure 2.4. Venn diagram illustrating 
shared and uniquely identified peptides 
in the pellet, supernatant and crude 
plasma samples. The diagram was 
generated by the workflow described in 
Figure 2.2. In total, 6,700-8,800 spectra 
were identified in each fraction. 
Additional information such as the isoelectric point of a protein or its 
molecular weight can be used as an extra dimension to filter out the 
erroneous identifications in samples fractionated in a pI or molecular 
weight-dependent manner. The Trans-Proteomic Pipeline already 
implements this for pI at the level of the peptides.  
The workflow also calculated the protein hydrophobicity or GRAVY score. 
When comparing protein abundance in the pellet and the supernatant 
fractions with respect to GRAVY score and protein molecular weight, we 
see - somewhat surprisingly – that the hydrophobicity has a very small 
effect on the precipitation in comparison with molecular weight (Figure 
2.5c). 
CONCLUSIONS 
Although blood plasma is one of the most popular sample sources in 
biomarker discovery, the large dynamic range of the protein concentration 
provides a serious challenge. As was shown by Kay et al. 28, albumin can be 
precipitated by simply adding acetonitrile. We have shown that adjustment 
of the pH prior to precipitation and addition of equal volume of acetonitrile 
was sufficient to remove approximately 90% of albumin and many other 
large proteins from the supernatant extracts. Moreover the proteome 
coverage has been increased by 25%. The procedure is simple, reproducible, 
can be quickly performed with common laboratory chemicals and  
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equipment, and is compatible with standard techniques such as SDS-PAGE 
and LC-MS/MS. The method may be applicable in many types of proteomic 
analyses of plasma and other samples. For instance, optimised organic 
precipitation can not only be used for the sample decomplexification but 
also to concentrate target proteins which might be an advantage in 
biomarker discovery. This method has been successfully implemented in 
urine proteomics.30 
Although the gain in protein coverage is lower than what can be achieved 
with immunoaffinity procedures, it should be emphasized that the present 
technique is robust and can easily be applied in large clinical studies. 
protein molecular weight (kDa)
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Figure 2.5. Histograms of the molecular 
weight (a) and predicted pI (b) 
distributions of proteins identified in the 
crude sample (solid, black), pellet 
(dashed, black) and supernatant (gray), 
accompanied by a graph with calculated 
GRAVY score plotted against protein 
molecular weight (c). In the latter, 
proteins marked by black circles have 
pellet to supernatant spectral count ratio 
≥2, by triangles ≤0.5, and by crosses 
more than 0.5 and less than 2. 
2
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Further improvements or adaptation of experimental protocols may focus on 
specific enrichment for protein modifications (sulfation, phosphorylation, 
glyco- or lipoproteins), as well as providing some constraints for the 
peptide/protein identification algorithms, such as limits on pI, molecular 
weight or post-translational modifications. Further optimization may also 
aim at improving the quality and albumin depletion of the pellet fraction. 
As an additional remark, the Taverna scientific workflow used in this study 
contains in a single workflow and interface all the steps from raw mass 
spectrometry data through format conversion, peptide identifications, 
statistical evaluation, data mining to visualization in figures essentially as 
they appear in this paper, completely automated and without any interactive 
manual input. The workflow and the data discussed here are available on-
line, enabling anyone to repeat the analysis or adapt the workflow for any 
other experiment comparing two or more tandem mass spectrometry 
datasets with respect to physico-chemical protein properties. 
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ABSTRACT
We have developed and implemented a novel mass spectrometry (MS) 
platform combining the advantages of high mass accuracy and resolving 
power of Fourier transform ion cyclotron resonance (FTICR) with the 
economy and speed of multiple ion traps for tandem mass spectrometry. The 
instruments are integrated using novel algorithms and software and work in 
concert as one system. Using chromatographic time compression, a single 
expensive FTICR mass spectrometer can match the throughput of multiple 
relatively inexpensive ion trap instruments. Liquid chromatography (LC)-
mass spectrometry data from the two types of spectrometers are aligned and 
combined to hybrid datasets, from which peptides are identified using 
accurate mass from the FTICR data and tandem mass spectra from the ion 
trap data. In addition, the high resolving power and dynamic range of a 12 
tesla FTICR also allows precise label-free quantitation. Using two ion traps 
in parallel with one LC allows simultaneous MS/MS experiments and 
optimal application of collision induced dissociation and electrontransfer 
dissociation throughout the chromatographic separation for increased 
proteome coverage, characterization of post-translational modifications 
and/or simultaneous measurement in positive and negative ionization mode. 
An FTICR-ion trap cluster can achieve similar performance and sample 
throughput as multiple hybrid ion trap-FTICR instruments, but at a lower 
cost. We here describe the first such FTICR-ion trap cluster, its performance 
and the idea of chromatographic compression. 
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INTRODUCTION
In recent years, mass spectrometry (MS) has become a popular method for 
identification and quantitation of proteins and metabolites in complex 
biological matrices. The reasons for this are at least 2-fold: mass 
spectrometry can separate a very large number of chemical species of 
different mass in a complex sample and, secondly, unknown peptides or 
proteins can be routinely and automatically identified by data-dependent 
tandem mass spectrometry (MS/MS). The resolution or peak capacity is 
increased further by coupling the mass spectrometer to a liquid 
chromatography (LC) system. Analytical challenges from the rapidly 
expanding field of proteomics have pushed the development of mass 
spectrometers in general and led to further optimization of systems for 
peptide and protein analysis. The workhorses in MS-based proteomics are 
ion traps.1 These are perfectly suited for on-line coupling to LC via 
electrospray ionization (ESI) and are capable of analyzing complex peptide 
mixtures by rapid MS/MS. Although ion traps are sensitive and versatile, 
they have relatively low resolving power (<104) and mass measurement 
accuracy (~100 ppm). In modern mass spectrometers, quadrupoles or ion 
traps are often used in hybrid configuration with a second mass analyzer, 
such as time-of-flight2 (TOF), Orbitrap,3 or FTICR,4, 5 within a single 
vacuum system. In these hybrid instruments, the ion trap provides rapid, 
sensitive MS/MS, or at least precursor ion selection, and the second 
analyzer accurate mass and high resolving power. The hybrid linear ion 
trap-Fourier transform ion cyclotron resonance (FTICR) mass spectrometer4 
can be considered to represent the current state-of-the-art in commercially 
available mass spectrometry instrumentation. An alternative paradigm to 
combining two mass analyzers in one physical instrument is to merge data 
from two different instruments analyzing the same sample. Several 
analytical strategies have been developed based on this general idea, notably 
the accurate mass and time tag (AMT) approach of Smith et al.,6 wherein 
MS/MS data from ion traps are used to validate peptide identifications based 
on accurate mass and to train a predictor of chromatographic retention 
times.7, 8 Accurate MS and ion trap MS/MS data can also be directly 
combined using chromatographic alignment.9, 10 All published hybrid 
instrument designs and previously published data fusion schemes are 
inefficient, at least timewise, in their use of the accurate mass detector. 
This is because the latter invariably has much higher resolving power than 
the ion trap used for MS/MS and thus is able to detect most species selected 
3
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for MS/MS on a considerably shorter chromatographic time scale. Given the 
difference in cost and size of ion traps (small and relatively inexpensive) 
and Orbitrap or FTICR mass spectrometers (larger and more expensive), it 
also makes economic sense to combine multiple ion traps with a single 
FTICR mass spectrometer. We have therefore designed and implemented an 
integrated FTICR-ion trap cluster, a system of mass spectrometers that work 
together as a single entity to analyze one sample stream using differential 
chromatographic gradients for LC-MS and LC-MS/MS. The use of a 
dedicated instrument platform is novel, but it is the concept and use of 
different chromatographic time scales that is important, rather than the exact 
configuration or number of ion traps. We will therefore describe the 
performance and consequence of chromatographic compression in detail and 
exemplify this approach with an application in a quantitative proteomics 
study. 
MATERIALS AND METHODS 
Test Samples 
For evaluation of the FTICR-ion trap cluster, we repeated the classic 
glucose/lactose diauxie experiment by Jacob and Monod.11 E. coli K12 
strain MG1655 was acquired from ATCC and cultured in 1 L MOPS 
minimal medium with 0.5 g/L glucose and 1.5 g/L lactose in a 3 L 
fermentor (Applikon Biotechnology, Schiedam, The Netherlands), 
duplicating as closely as possible the recent glucose/lactose diauxie gene 
expression study by Traxler et al.12 The culture was monitored by 
spectrophotometric OD600 measurement, glucose concentration measured 
using a glucose oxidase assay kit (Sigma-Aldrich Chemie B.V., 
Zwijndrecht, The Netherlands) and lactose concentration followed using a 
galactosidase/lactose kit (BioVision, Mountain View, CA, USA). Three 
replicate cultures were sampled at approximately –100, –50, –10, 0, 10, 20, 
30, 40, 50, and 60 min relative to the diauxic shift. Proteins were extracted 
using the Novagen “BugBuster” kit (Merck KGaA, Darmstadt, Germany), 
following the manufacturer’s recommended protocol with 5 mL of lysis 
buffer per gram of wet cell weight.  
For identification, 25 µg protein from two time points, one before and one 
after the diauxic shift, was fractionated using SDS-PAGE (NuPAGE 8%–
12%; Invitrogen, Carlsbad, CA, USA) by cutting the gel lane into 26 two-
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mm bands, reduced (10 mM DTT, 56 °C, 45 min), alkylated 
(iodoacetamide, room temperature, 1 h in dark) and digested in-gel using 
trypsin (sequencing grade; Promega, Madison, WI, USA). For quantitative 
measurement, 250 µg of protein from each individual sample was digested 
as above but in solution and 2 µg of each digest injected on column. 
To compare the sensitivity and quantitative precision, bovine serum albumin 
(BSA) was spiked into an E. coli protein extract from a post-diauxie time 
point at BSA-to-E. coli ratios of 0, 0.01%, 0.1%, 1%, and 10%. The 
digestion protocol was the same as for the gel slices except for the omission 
of the destaining and washing steps. The spiked samples were analyzed in 
an iterated sequence from low to high concentration BSA, with a blank after 
the highest concentration. 
FTICR-Ion Trap Cluster 
All LC systems in the FTICR-ion trap cluster are parallel, splitless NanoLC-
Ultra 2D plus (Eksigent, Dublin, CA, USA) for ultra-high-pressure parallel 
LC with an additional loading pump for fast sample loading and washing. 
For this work, all LC systems were configured with 300 µm-i.d 5-mm 
PepMap C18 trap columns (Dionex, Sunnyvale, CA, USA), 15-cm 300 µm-
i.d. ChromXP C18 columns supplied by Eksigent and running linear 
gradients, all from 4% to 44% acetonitrile in 0.05% formic acid, but of 
different lengths. 
The FTICR is a solariX 12 T FTICR (Bruker Daltonics, Bremen, Germany) 
equipped with an Apollo II ESI source and external quadrupole for 
precursor ion selection and/or MS/MS outside the cell. In the FTICR ion 
trap cluster, this quadrupole is only used as an ion guide with transmission 
optimized for m/z 400–1000, which includes most doubly- and triply 
charged tryptic peptides. Typically 220 (~106) data points are acquired per 
spectrum, and one spectrum is acquired every 2–3 s. 
The ion traps in the particular instrument cluster used to generate all data 
shown here were of two models, both from Bruker Daltonics, with one HCT 
ultra PTM Discovery system for collision-induced dissociation (CID) and 
electron-transfer dissociation (ETD), and one standard HCT ultra system 
exclusively for CID combined in pairs and connected to a single LC system. 
After each MS scan, up to five abundant multiply charged species in m/z 
300–1300 were selected for MS/MS and excluded for 1 min after being 
3
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selected twice. For spectral counting no active precursor exclusion was 
used. 
Each mass spectrometer is controlled by a dedicated computer, but all 
instruments are monitored from a single desk with two monitors using dual 
4-port KVM switches. The LC systems are controlled using the HyStar 3.2-
3.4 with a plug-in from the LC manufacturer, the ion traps by 
esquireControl 6.2 and the FTICR by apexControl 3.0, all from the 
instrument manufacturer. The acquired data from each mass spectrometer is 
automatically transferred to a dedicated server and processed as described 
below. 
Data Analysis 
Automation of data analysis tasks is essential for the easy operation of the 
instrument cluster. All data is continuously copied over a gigabyte/s 
Ethernet connection to a dedicated data processing server. By using a 
convention with delimited LC mass spectrometer species and unique sample 
identifiers in the HyStar sample lists, and consequently the resulting 
filenames, the ion trap data can be automatically searched against a species-
specific sequence database using a local installation of X!Tandem.13 The 
identified peptides are then used to align each ion trap dataset with the 
corresponding FTICR dataset from the same sample in the “hybrid 
instrument emulation mode,” as previously described.10 Additionally and 
optionally, identified and aligned peptides can also be used to internally 
calibrate the FTICR mass spectra,14 generating a hybrid peak list with sub-
ppm precursor mass measurement uncertainty. The hybrid peak lists are 
then automatically searched against the same database but with a narrow 
precursor (peptide) mass tolerance window. The data analysis so far is 
performed in the background without any user input. The processing scripts 
and all software used for the alignment of LC-MS and LC-MS/MS datasets 
and for integrating peak areas in the LC-MS data will be freely available as 
open source on http://www.ms-utils.org/cluster. All analyses can also be 
performed in batch-mode and off-line, allowing the use of other search 
engines such as Mascot15 or Phenyx16 running on separate servers. For the 
data presented in this paper, we exclusively relied on Mascot, as it is the 
most common of the search engines available in our lab. All quantitative 
analyses are currently only performed in batch-mode. All FTICR datasets 
are searched for all identified peptides in a narrow retention time window 
and a very narrow m/z window (typically ±2 ppm, as low signal-to-noise 
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peaks have larger mass measurement errors) to retrieve quantitative 
information of all identified peptides in each biological replicate. The 
quantitation is done by adding all signals in this narrow m/z and time 
window. This only requires that the last chromatographic dimension used 
with the ion traps for identification can be aligned with that used with the 
FTICR for quantitation. All peptide intensities are then summed to total 
protein intensity. 
RESULTS
FTICR-Ion Trap Cluster 
The basic working principle of the FTICR-ion trap cluster (Figure 3.1) is 
that each compound in each sample is analyzed twice, once on the FTICR 
for accurate mass determination and once on an ion trap for MS/MS. The 
high resolving power of the 12 tesla (T) FTICR mass spectrometer allows 
many simultaneous accurate mass determinations also in very complex 
spectra. All mass spectrometers in the cluster are coupled on-line to parallel 
ultra-high-pressure LC systems for efficient use of the mass spectrometers 
and high chromatographic peak capacity. The new and enabling idea behind 
the FTICR-ion trap cluster is the use of short and long chromatographic 
gradients, respectively, with a single accurate mass/high-resolution mass 
spectrometer, here a 12 T FTICR, and multiple rapid and sensitive MS/MS 
instruments, here 3 × 2 state-of-the-art ion traps. These two independent LC 
separations are performed in such a way that the single FTICR can keep up 
with the throughput of and provide accurate MS data to the MS/MS data 
from the multiple ion traps, for instance by compressing the gradient a 
factor equal to the number of ion traps or ion trap “modules” in the system, 
where a module is defined as one or more ion traps coupled to a single LC 
(see Figure 3.1). The specific ion trap cluster described here combines one 
ion trap for ETD17 with one ion trap for CID in each of three such modules 
in the system. The use of separate instruments allows different 
configurations, the most straightforward being one LC system per ion trap. 
However, there are some advantages in the use of two ion traps in parallel to 
one LC. In these ion traps, there is significant dead time in the switching 
between CID and ETD. Using two ion traps where one is dedicated to CID 
and one to ETD not only improves duty cycles, but in principle allows the 
instruments to be tuned and optimized for a particular dissociation method, 
3
Chapter 3 70 
including precursor ion selection criteria. For complex samples, it is also 
well known that ion traps cannot sample all detected peptides for MS/MS on 
any reasonable chromatographic timescale. It is also feasible to combine 
data from split samples acquired on two or more LC-ion trap systems with 
one LC per ion trap. The data acquisitions then need not be concurrent, but 
the results from one acquisition can be used to make an exclusion list for the 
next. 
Automated integration of accurate mass determinations from the FTICR 
with a large number of MS/MS spectra from the ion traps is key in the 
instrument cluster, and alignment and combination of accurate MS data 
from FTICR and MS/MS data from ion trap mass spectrometers improves 
confidence in peptide identifications and makes it possible to identify 
MS/MS spectra of lower quality, resulting in more peptide and protein 
identifications at a given false discovery rate.10 The ion trap and FTICR data 
acquisitions are physically and timewise independent which allows the 
instrument cluster to be operated in different modes. We call two basic  
Figure 3.1. The FTICR-ion trap cluster consists of six ion traps grouped in three pairs. In 
each pair, the eluent from one capillary LC system is split in two, with half going to a CID-
only ion trap and half to an ETD-capable ion trap. The ion traps are used for fast MS/MS 
acquisition. The FTICR component consists of an identical capillary LC system as used 
with the ion traps and a 12 T solariX Qq-FTICR. Although capable of MS/MS and even 
MSn, the FTICR is used exclusively for accurate MS and quantitation in this instrument 
cluster. 
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modes the “hybrid instrument emulation” mode and the “quantitative 
accurate mass and time tag” (QAMT) mode, respectively (Figure 3.2). 
In the hybrid instrument emulation mode, each sample is analyzed on both 
the ion trap and FTICR platforms, and the data aligned and combined to 
hybrid datasets with accurate precursor ion masses from FTICR and MS/MS 
from two ion traps, for instance both CID or one CID and one ETD (a 
detailed comparison of different CID/ETD schemes was recently published 
by Leinenbach et al.18 These hybrid datasets are complete as each tandem 
mass spectrum is supplied with an accurate precursor mass, and similar in 
quality to what would be obtained from a hypothetical ETDcapable 12 T ion 
trap-FTICR instrument. If the FTICR dataset is acquired first, inclusion lists 
can be made based on the accurate mass for subsequent MS/MS in the ion 
traps, just as in a hybrid instrument. The latest version of the ion trap control 
software allows for scheduled precursor lists with m/z as well as elution 
time windows of precursors to be selected for MS/MS. The QAMT mode 
uses a different set of samples, or fractions of a representative or pooled 
Figure 3.2. Repeating scheduling blocks for the FTICR-ion trap cluster with 3 _ 2 ion traps 
in the hybrid instrument emulation mode (a) and quantitative accurate mass and time mode 
(b). If these schedules are kept, the FTICR and ion trap cluster will require exactly the same 
time for the analysis of a batch of samples. It is not necessary to strictly adhere to such time 







sample for identification of peptides quantified in individual biological 
replicates, time points or experimental conditions by the FTICR. This is 
similar to the AMT scheme by Smith et al. but the emphasis here is on the 
FTICR providing both quantitation and accurate MS to increase confidence 
in peptide identifications. The FTICR-ion trap cluster also allows the on-
the-fly generation of the AMT database. 
Dataset Alignment and Chromatographic Compression 
An E. coli whole-cell lysate obtained as described in the Methods section 
was analyzed using linear chromatographic gradients of 9, 10, 11.3, 12.9, 
15, 18, 22.5, 30, 45, and 90 min corresponding to compression ratios of 10:1 
down to 1:1. The previously described alignment algorithm10 had been 
designed to be as general and robust as possible, and was found to be 
insensitive to chromatographic time scales. Without modification, the 
algorithm correctly aligned datasets from the different chromatographic time 
scales (Figure 3.3). The elution times depend linearly (R2 > 0.99) on 
compression ratio, as expected (Figure 3.4a). However, the alignment is 
more robust, or reproducible, for lower compression ratios, as indicated by 
the larger variation in the slope of the piecewise linear alignment. This is 
caused by the software having to look for the precursor m/z in a larger 
relative time window at higher compression ratios. The alignment is very 
robust up to at least a compression ratio of 3:1, which is the number of ion 
trap modules and the highest compression ratio in our setup. 
Figure 3.3. Automatic alignments (lines) 
of FTICR and ion trap datasets with 
chromatographic compression 
FTICR:ion trap 1:1, 1:2, 1:4, and 1:8, 
showing the peptide features contributing 
to the fitness function in the genetic 
algorithm used for alignment (dots). All 
alignments were performed allowing a 
25 scan residual standard error, mass 
measurement error tolerance ±1 ppm and 
262 unique peptides identified with a 
Mascot ion score cutoff 30. The squares 
represents the breakpoints in the 
piecewise linear alignments. No 
parameters needed to be adjusted to align 
chromatograms of different time scales. 
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Figure 3.4. The slope of the main 
segment of the piecewise linear 
alignment as a function of 
chromatographic compression (a). The 
plotted slope for four replicates at each 
compression ration was normalized to 
compensate for the different data 
acquisition rates in the FTICR and ion 
traps. The retention times of matched 
peptide features have a linear 
dependence on the length of the 
chromatographic gradient, but alignment 
is more difficult at higher compression 
ratios. More features are also lost, or not 
observed, within ±1 ppm in the expected 
elution time window, the more the 
chromatographic gradient is compressed 
on the FTICR (b). These numbers are 
derived from the relatively abundant 
peptides identified by MS/MS. For lower 
abundant species not identified by 
MS/MS, the fraction lost is likely larger. 
Another cost of compression of chromatographic gradients is that fewer 
features (here peptides) are observed at higher compression ratios. This can 
be quantified as the fraction of species tentatively identified by MS/MS in 
the ion traps and above the detection limit and within ±1 ppm of the 
theoretical mass in the FTICR. The fraction of identified peptides retained 
as a function of chromatographic compression is shown in Figure 3.4b. Note 
that the percentage of preserved features decreases smoothly as a function of 
chromatographic compression, from around 98% with no compression to 




from 90 to 30 min, 94% of the peptides selected for MS/MS are retained. 
This limited loss is compensated with nearly 200% gain in throughput. 
There will probably always be some tradeoff between coverage and 
measurement throughput in proteomics. The FTICR-ion trap cluster is no 
exception, even though it is designed to provide a relatively deep coverage 
using high-field FTICR with a high throughput using chromatographic 
compression and multiple ion traps. It is important to keep in mind that 
these numbers refer to peptides selected for MS/MS and producing good 
CID spectra in the ion traps, and not all features detectable by MS. The 2% 
“lost” peptides with identical chromatographic gradients is comparable to 
what would be expected between repeated analyses on the same system and 
are comprised of erroneous peptide identifications from the ion trap data 
alone, peptides measured outside the tolerated and searched m/z window in 
the FTICR, and peptides falling below the detection limit in the FTICR. 
Gygi and coworkers have reported “losses” of a similar magnitude between 
LTQonly and LTQ-FT datasets, where slightly more MS/MS spectra are 
acquired and a few more (unmodified) proteins identified using only the 
LTQ rather than the hybrid LTQ-FT,19, 20 so this is not a phenomenon 
unique to the FTICR-ion trap cluster. In the FTICR-ion trap cluster, the 
MS/MS data is acquired in the ion traps completely independently from the 
FTICR, without any time loss. 
High Throughput Quantitative Proteomics 
Label-free quantitation using FTICRMS is more precise and covers a larger 
dynamic range in relative protein abundance than label-free quantitation 
using only ion traps, for instance with the emPAI spectral counting 
method21 (Figure 3.5). Good agreement with calculated isotopic 
distributions and precise relative quantitation using 15N-labeling and 
FTICRMS has also been reported previously.22 The FTICR-ion trap cluster 
is ideally suited to study proteome dynamics, analyzing large cohorts of 
similar samples. We have chosen to illustrate the throughput and 
applicability of the instrument cluster with a time-course study of the 
glucoselactose diauxie11 in E. coli. A subset of the data is shown in Figure 
3.6 and compared with a recently published gene expression study.12 The 
diauxie experiment serves as a positive control, as we expect to see β-
galactosidase to be the most up-regulated protein during the glucose-lactose 
shift. A 10-fold increase in abundance of this protein could also be observed 
in each of the three replicate time series (Figure 3.6). This quantity and 
quality of data can be routinely generated in less 24 h using the FTICR-ion  
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trap cluster, illustrating the power of the system in large-scale proteomic 
studies. 
With sufficient protein or peptide fractionation or enrichment, the number of 
identified peptide features may eventually exceed the number of observable 
peptide features in the FTICR data. The more identified peptides, the larger 
the risk of false matches between FTICR and ion trap data. However, the  
Figure 3.5. Comparison of technical reproducibility (quantitative precision) and dynamic 
range between FTICR and the emPAI21 method for label-free quantitation using three 
replicate measurements of BSA spiked in a constant background of E. coli cell lysate at 
each of five relative abundance levels: 0, 0.01%, 0.1%, 1, and 10% of the background of E. 
coli protein. The FTICR signal abundance is the total peak intensity integrated (40 scans 
around the chromatographic maximum in a region ±5 ppm and ±25 scans from the m/z and 
retention time predicted from the ion trap MS/MS data) over the chromatographic peaks of 
28 identified BSA peptides, without normalization. No BSA peptides were identified in the 
ion trap at the 0 or 0.01% spike level, and only a single peptide in one of the replicates at 
the 0.1% level. At the 1% and 10% levels, spectral counting works well, with relative 
standard error of 19% at the 1% spike level and 9% at the 10% spike level. Conversely, the 
relative standard error of the FTICR measurement is around 3% at and above the 0.1% 
level, and 12% at the 0.01% level. Both the limit of detection and limit of quantitation, as 
functions of relative abundance, are approximately two orders of magnitude lower in the 
FTICR method than with spectral counting from the same sample. In this comparison, the 
same spiked samples and 90-min gradients were used for the ion trap and FTICR analyses. 




Figure 3.6. Protein (a) and gene (b) 
expression in Escherichia coli K12 
during glucose-lactose diauxie, showing 
100 out of 948 proteins (630 with more 
than one peptide) quantified at 10 time 
points across three biological replicates – 
a total of 27,492 (18,270 with multiple 
peptides) quantitative protein abundance 
measurements by the FTICR-ion trap 
cluster. Cyan color denotes increase, 
yellow decrease, and black no change. 
The times are relative to the onset of 
diauxic shift as observed by OD600 
measurement. These data can be 
obtained in less than 24 h using the 
instrument cluster. The figure shows 
~10% of the total proteomic dataset (see 
Supplemental Information, which can be 
found in the electronic version of this 
article) compared with the corresponding 
gene expression data from a similar 
experiment by Traxler et al.12 The 
protein with the strongest increase in 
abundance during the glucose-lactose 
diauxic shift is β-galactosidase/lacZ, as 
expected (marked in red). 
situation may be improved by good mass measurement accuracy (<0.5 ppm 
standard error in the 12 T FTICR after automatic internal calibration) 
chromatographic reproducibility and restricting the number of peptides of 
similar mass and elution times, which is essentially the idea behind the 
accurate mass and time tag approach. Most importantly, the false matches 
between the FTICR and ion trap data is expected to increase with the 
difference between the individual samples analyzed by the FTICR and the 
sample or samples used for fractionation and peptide identification. 
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Quantifying samples from individual time points or experimental conditions 
using one or more pooled samples from the same experiment for 
identification is likely to reduce the risk of false matches. In the pipeline 
described here, we also strive to use all available information, which 
includes using at least all peptides with a sequence unique to a protein for 
protein identification and quantitation. This way, the false positive rate can 
be much lower on the protein level than on the peptide level, the confidence 
generally increasing the more peptides are available for identification and 
quantitation per protein. 
DISCUSSION
The first implementation of an FTICR-ion trap cluster described here was 
designed for robustness and optimal instrument performance using state-of-
the-art ion trap and 12 T FTICR mass spectrometers, capillary ultra-high-
performance liquid chromatography systems and standard ESI source, 
operating at 2 µL/min. We have chosen a 12 T system as it provides 
highperformance at a reasonable cost. The chromatographic alignment is 
more robust the more features are used for alignment, i.e., the more 
information that is available for alignment. However, the time required for 
evaluation of the fitness function in the genetic algorithm is proportional to 
the number of features or peptides used for alignment. In our experience, it 
is a good practice to limit the number of features to at most a few 
thousand.23 For peptides, this is easily done by raising the search engine 
score threshold. At the other end, the algorithm does not need more than 30–
40 matched peptides distributed over the chromatographic separation to 
produce a good alignment.10 
Fragmentation by CID is the most commonly used method for MS/MS in 
general as well in the ion trap cluster. However, peptides with labile post-
translational modifications such as phosphorylation or glycosylation often 
lose these before producing sequence-specific backbone fragments by CID, 
thus preventing the exact localization of the post-translational modification. 
The recently introduced ETD in linear and three-dimensional ion traps is 
therefore extremely useful for primary structure determination of peptides 
containing posttranslational modifications, and has been rapidly 
implemented and accepted in the field. Electron-transfer dissociation, like 
electron capture dissociation24 in Fourier transform ion cyclotron resonance 
(FTICR) mass spectrometers, cleaves N–Cα bonds of a peptide backbone 
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more or less evenly and cleavages are less dependent on amino acid 
sequence than in CID. Often labile post-translational modifications are 
retained after ETD of the backbone, making it possible to localize the 
modified amino acid residue. Each ion trap module in the FTICR-ion trap 
cluster therefore contains one ion trap equipped for ETD. 
The resolving power and dynamic range of the FTICR is taken full 
advantage of for quantitative peptide and protein measurements. The system 
is ideal for large-scale quantitative proteomic studies, using labelfree 
quantitation or stable-isotope labeling methods such as SILAC25 or 
multiplexed 15N-labeling.22 Despite its performance, the cluster has some 
limitations. For instance, it is not ideally suited for iTRAQ26, 27 
measurements, as these require MS/MS for the relative quantitation. The use 
of capillary rather than nanoflow LC reduces absolute sensitivity, but we 
have chosen this option as the chromatography systems and ESI sources 
require considerably less maintenance than in typical nanoflow systems. 
This robustness is essential in large-scale studies. Data-dependent precursor 
ion selection based on accurate mass in real time is also not possible in the 
cluster. However, it is possible to first perform the FTICR analysis and then 
use the accurate mass information to construct so-called scheduled precursor 
lists (inclusion criteria based on time as well as m/z) for one or more of the 
ion traps. For instance, species suspected to be phosphorylated based on 
accurate mass measurement28 could be targeted for MS/MS using ETD, or a 
combination of CID and ETD. Moreover, the loose coupling of the 
instrumentation and nonconcurrent (or not necessarily concurrent) 
acquisition of MS and MS/MS data allows great freedom in constructing 
and exploring novel schemes for datadependent acquisition, as the analyses 
of the MS data dos not have to be performed in real-time and integrated into 
the instrument control software. 
To appreciate the QAMT analysis mode, one can consider the following 
experiment. Assume n replicates of b biological samples or experimental 
conditions are collected, in total n × b samples to be analyzed on a cluster 
with c ion trap modules. Each sample and replicate is digested by trypsin 
and analyzed by LC-FTICR using reversed-phase chromatography only. In 
parallel, the proteins or digests of the replicates of each type of biological 
sample are pooled and fractionated by, for instance, SDS-PAGE (proteins) 
or strong cation exchange chromatography (peptides), into c × n fractions, 
for a total of c × n × b fractions. For three ion trap modules and four 
biological replicates, 12 fractions would be collected for each of the b types 
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of biological sample. These fractions are subsequently analyzed on one of 
the ion trap modules in the cluster. In such a case, the same length 
chromatographic gradients can be used with the FTICR and the ion traps, 
with the total analysis time on the FTICR exactly matching that of the ion 
traps. For example, with 60-min LC methods and three ion trap modules, the 
independent quantitative analysis of four biological replicates of six 
different conditions or time points with 12 SCX peptide fractions collected 
for each takes 24 h, generating 24 LC-FTICR analyses for quantitation, and 
72 ion trap LC-MS/MS datasets for identification. The peptides are 
quantified in a similar manner as in the AMT protocol6 by integrating the 
area under the LC-MS peak in the FTICR data for the major peak in a 
narrow m/z range and the predicted retention time window. All “AMT tags” 
are confirmed by MS/MS on one of the ion traps on at least one similar 
sample from the same study, although not necessarily for every individual 
sample, treatment, or time point. This also means that peptides (and 
consequently, proteins) can be quantified at much lower levels than are 
needed for confident identification by MS/MS, which is also illustrated by 
the BSA measurements summarized in Figure 3.5. Under ideal LC 
conditions, the elution time of a peptide in the last, reversed phase 
dimension does not depend on which protein or peptide separation or 
separations were used in the prior dimensions, e.g., which SCX fraction is 
analyzed, and the elution times in the last (reversed-phase) dimension on the 
LC-ion trap systems can be aligned with those in the only (reversed-phase) 
LC separation with the FTICR. This QAMT scheme is feasible as the 12 T 
FTICR has sufficient resolving power and dynamic range for the c × n-fold 
higher sample complexity compared to the ion trap LC-MS/MS. Analogous 
schemes can be constructed for any number and type of peptide or protein 
fractionation before the final reversed-phase separation, for instance, 
proteins can be fractionated by SDS-PAGE and digested for identification 
by LCMS/MS while individual samples are analyzed by LC-FTICR MS 
only. 
As illustrated by the E. coli diauxie example, the QAMT mode is 
particularly useful for comparison of relatively similar samples, such as a 
series incorporating different time points, treatments, or experimental 
replicates. It is then feasible to use a two-dimensional separation before 
MS/MS, where the second dimension is of the same type, e.g., reversed-
phase, as the one used as the only LC dimension for FTICR-MS. A high-
field FTICR mass spectrometer is capable to resolve and detect more than 
10,000 peptides in a relative short chromatographic separation, and the 
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additional dimension of separation aids the identification in the ion traps. 
Complex peptide mixtures have even been analyzed by direct infusion and 
high-field FTICR, i.e., without prior separation.29, 30 For instance, we 
recently demonstrated that even by direct infusion, it is possible to detect 
and resolve most peptides in a combinatorial library with more than 1000 
unique elemental compositions spanning a factor 36 in concentration.31 For 
a very large number of biological replicates, the scheme becomes similar to 
the AMT tag protocol developed by Smith et al.,7, 32, 33 where the “AMT 
tags” are verified at least once by MS/MS, placed in a database, and aligned 
through normalization of the retention times with the accurate mass data 
from an FTICR.9 A particular advantage of the AMT or QAMT mode is that 
it is still possible to quantify peptides and proteins in samples where they 
are present at a lower concentration than would be required to produce good 
MS/MS data, which is required to generate any quantitative information in 
many other methods such as iTRAQ or spectral counting.21, 34 
The FTICR-ion trap cluster provides quantitative proteomics data of a 
similar quality with comparable throughput to that of multiple hybrid ion 
trap-FTICR or ion trap-Orbitrap instruments at lower cost and infrastructure 
requirements. The instrument cluster has a few limitations, but in turn opens 
up additional possibilities for data-dependent MS/MS acquisition, and can 
serve as a test bed for the design and development of hybrid instruments 
with a single accurate mass analyzer and multiple ion traps for MS/MS. The 
cluster design and idea of chromatographic compression between LC-MS 
and LC-MS/MS is not limited to the use of a high-field FTICR and six ion 
traps, but may also be applicable to the combination of one MS-only TOF or 
Orbitrap with one or more MS/MS-capable mass spectrometers, albeit with 
lower mass accuracy and resolving power than any high-field FTICR 
instrument. The cluster scheme provides an inexpensive means to adding 
accurate mass capability in laboratories already operating one or more ion 
trap instruments for LC-MS/MS. All components in the cluster are 
individually exchangeable, which provides a high degree of flexibility that 
can be used to continuously upgrade the system. For instance, during the 
first year of operation, the 12 T FTICR front-end was upgraded from a 
previous apex ultra model to the recently introduced solariX. 
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ABSTRACT
Data analysis in mass spectrometry-based proteomics struggles to keep pace 
with the advances in instrumentation and the increasing rate of data 
acquisition. Analyzing this data involves multiple steps requiring diverse 
software, using different algorithms and data formats. Speed and 
performance of the mass spectral search engines are continuously 
improving, although not necessarily as needed to face the challenges of 
acquired big data. Improving and parallelizing the search algorithms is one 
possibility, data decomposition presents another, simpler strategy for 
introducing parallelism. We describe a general method for parallelizing 
identification of tandem mass spectra using data decomposition that keeps 
the search engine intact and wraps the parallelization around it. We 
introduce two algorithms for decomposing mzXML files and recomposing 
resulting pepXML files. This makes the approach applicable to different 
search engines, including those relying on sequence databases and those 
searching spectral libraries. We use cloud computing to deliver the 
computational power and scientific workflow engines to interface and 
automate the different processing steps. We show how to leverage these 
technologies to achieve faster data analysis in proteomics and present three 
scientific workflows for parallel database as well as spectral library search 
using our data decomposition programs, X!Tandem and SpectraST.  
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INTRODUCTION
Mass spectrometry (MS), particularly tandem mass spectrometry (MS/MS), 
is currently the most used method for identifying unknown proteins present 
in biological samples. Advances in instrumentation have reduced 
acquisition time and increased resolution and  sensitivity, which in 
combination with complementary fragmentation mechanisms1, 2 and high 
resolving-power mass analyzers in both MS and MS/MS3-5 have led to very 
complex data. This has brought new challenges to proteomics, i.e. how do 
we store and process these large data volumes. Standard desktop computers 
often cannot process data at the rate it is being generated, creating an 
additional bottleneck in the analysis pipeline. The analysis of the mass 
spectrometry data typically involves several steps. One essential and 
computationally expensive step is peptide identification, i.e. the mapping of 
each spectrum to a unique peptide or one or more peptides. In this 
manuscript we describe a method of handling mass spectrometry “big data” 
by outsourcing computationally intensive tasks using off-the-shelf open 
source tools and in-campus cloud resources. We introduce a method for 
parallelizing common search engines like X!Tandem and SpectraST that are 
part of the Trans-Proteomic Pipeline (TPP)6, which can also work for most 
other available search engines. We show how peptide identification speed 
using workflow engines, cloud computing, and a new data 
decomposing/recomposing algorithm can easily be improved by a 
significant factor. In our tests we reached more than 30-fold speed 
improvement comparing X!Tandem running locally (one core) with the 
same program running on the cloud and a 7-fold improvement for the 
SpectraST spectral library search.
METHODS
One important step in the processing pipeline of mass spectrometry data is 
associating a particular (tandem) mass spectrum with a peptide sequence. 
There are three types of search engines for peptide identification, i.e. 
database, library, and de novo. Database search engines, like Mascot7,
SEQUEST8, or X!Tandem9, compare each spectrum obtained from the 
sample with theoretical spectra generated from a list of predicted peptides. 
The predicted peptides list is ideally derived from all of the protein 
sequences that could be expressed in the experiment sample. Library search 
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engines, like SpectraST6 or X!Hunter10 assume that the fragmentation of a 
particular molecule in a mass spectrometer is partially reproducible between 
analyses and instruments. One can therefore generate a library of ion 
fragmentation spectra with each spectrum being associated with a 
corresponding molecular structure. A library search engine assigns a 
specific structure to an experimental spectrum by comparing it with the 
entries in the library.
Peptide identification using a search engine is a main processing bottleneck 
in mass spectrometry based proteomics. A normal search of 30,000 spectra 
could take up to 40 minutes on common modern desktop with a 4-core 
processor, depending on the search parameters. In many cases this is 
impractical for scientists, especially if they want to include more 
modifications in their searches, which can significantly increase the search 
space. Enhancing search engine speed besides developing search algorithms 
for high performance computing environment are continuously under 
development.11-14 While making faster algorithms is a main objective of 
several groups14-17, we are only targeting the data itself leaving the search 
engine intact. This makes the approach applicable to many search engines. 
Search engines are legacy software that have gained acceptance and 
usability in the proteomics community and we therefore prefer to consider 
them as black boxes and not modify them in any way, but instead wrap the 
parallelization around them. In the rest of the section we describe the data 
formats used, the new decomposition and recomposition algorithms, the 
processing pipelines and how to scale these up to scientific workflows. 
Data formats
To build on other efforts, such as the TPP6, we chose to use common XML 
formats such as mzXML18, 19 for input and pepXML20 as output. mzXML 
and pepXML are two de facto open format standards still used for mass 
spectrometry data. Converters from almost any other format to mzXML or 
pepXML can be obtained.19-21 Extension of our method to mzML22 is also 
feasible, as only the logic in the data decomposition algorithm needs to be 
modified with no further changes. Using open standard formats maintains 
compatibility with other efforts and existing pipelines and avoids making 
this work an isolated solution. 
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Data decomposition and recomposition
Decomposition involves breaking down a complex system into smaller 
pieces. It is the basis for finding the tasks that can run concurrently in 
parallel applications. There are two major decomposition methods in 
parallel programming, i.e. functional and data decomposition.23 Data 
decomposition is used more often and it depends mainly on the developer’s 
knowledge about the data and how an algorithm processes the data. In order 
to facilitate parallelism of peptide identification of mass spectrometry data 
we developed two algorithms for decomposing and recomposing the inputs 
and outputs of an arbitrary search engine. The only assumption made is that 
each spectrum will be processed by the search engine independently from 
other spectra. This is true for many search algorithms, but not subsequent 
validation steps, such as PeptideProphet24 and Percolator.25 However, the 
latter are not nearly as computationally expensive as the initial peptide-
spectrum matching. The search engines we used to demonstrate our 
parallelization approach, i.e. X!Tandem without model refinement26 and 
SpectraST process each spectrum independently. OMSSA27, MS-
GFDB/MS-GF+1 and Crux/Tide16, 17 are other search engines that could also 
be parallelized in this way. 
Processing Pipelines and Scientific Workflows 
There are multiple software packages that allow stepwise processing of 
mass spectrometry data, such as TPP6, Proteomatic28 and ProteoWizard.29 In 
this sense, processing pipelines and workflows are overloaded terms, and 
sometimes used synonymously. We use processing pipelines to refer to a 
multistep sequential processing of one dataset at a time, in which transitions 
from one step to the next happen with some manual interaction as in the 
TPP. Scientific workflows involve concurrency and parallel processing 
capabilities, in which the transition between the processing steps can happen 
automatically or with breakpoints according to the workflow design. 
Scientific workflow engines like Galaxy30, Moteur31, Kepler32, and 
Taverna33 were introduced in the last decade to facilitate interfacing 
modular processing steps, automating analysis pipelines, scaling them up to 
workflows, and make analyses reproducible and sharable. We have 
previously described34 how Taverna can be used to automate analysis 
workflows in mass spectrometry based proteomics on a local machine. We 
also demonstrated how workflow and data decomposition can scale up 
processing pipelines to run in high performance computing environments.23
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Here we use Taverna 2.4 to build our processing workflows and to perform 
job orchestration, i.e. to manage data and software transfer to and from the 
cloud. In this respect, we use Taverna not only as a workflow manager, but 
also as a technical enabler to build our adhocratic35, 36 experiment oriented 
distributed computing environment using in-campus clouds. Taverna offers 
various kinds of processors.33, 37 Scientists can chose between WSDL web 
services, Beanshell processors, REST Web services, Rshell processors, 
Tools and XPath processors. Details about these processors and how to use 
them can be found in literature33 as well as in the Taverna documentation.37
In the following we highlight the two processor types that are important for 
our implementation.  
Beanshell processors enable executing small Java code snippets as part of a 
workflow. Typically they are used for small tasks like simple file and data 
manipulation, parsing and formatting, saving to a local directory, calling 
local program, interacting with the user, etc. Tool processors are very 
suitable to call commands in a shell on any machine, to which Taverna can 
obtain an SSH connection - including the local machine. We mainly use 
Beanshell processors to launch software with their correct inputs locally, 
and Tool processors to interact with the cloud resources, upload data, and 
retrieve results. We used cloud resources based on the open source cloud 
middleware OpenNebula.38 These cloud resources are freely available for 
academic research users in the Netherlands. Such resources are common in 
various universities. A cloud environment in regard to our method can 
include any machine, to which Taverna could have an SSH connection. 
Used Datasets for Testing 
In order to profile our method and compare it with the local run of the used 
search engines we ran multiple tests from realistic database search 
scenarios. For these tests we used two ion trap datasets; the first consisted of 
5 LC-MS/MS datasets from tryptically digested human serum samples and 
the second of LC-MS/MS data from 20 fractions of one E. coli whole cell 
lysate, also digested with trypsin. All data was acquired on amaZon ion trap 
mass spectrometer (Bruker Daltonics, Bremen, Germany). The five human 
datasets each contains around 27,000 spectra whereas the 20 E. coli datasets 
each contains around 10,600 spectra (see Table 4.1 and Figure 4.6). In the 
X!Tandem search, strict tryptic cleavage specificity were assumed (C-
terminally or R and K, not N-terminally of P), the precursor mass 
measurement error tolerance -0.5 to 2.5 Da, 2 missed enzymatic cleavage 
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allowed, and carbamidomethylation as the only and fixed modification. 
Phosphorylation as variable modification and semi-tryptic cleavage were 
also considered in the performance tests. In the SpectraST search, average 
masses instead of monoisotopic masses were used and precursor mass 
measurement error tolerance of 3 Th. All other parameters for X!Tandem 
and SpectraST were as the defaults in the TPP package. For the X!Tandem  
One sample (human) 5 samples (human) 20 samples (E. coli)
Size of 
file(s) 113.8 MB 565.8 MB 1,540 MB 
Number
of spectra 27,436 139,211 212,141 
Search






























2:15 4:17 5:42 7:09 10:34 11:31 
Speedup
in fold 18 / 4.6 6.8 34 / 10 7 3.8/2.7 3.8 
1 The used system to run all the local experiments was an HP Elite 8200 computer with Windows® 7 
Enterprise 64bit operating system, Intel® i7-2600 processor running at 3.40 GHz, and 8 GB of RAM.  
2 Wall time here refers to the actual time experienced by the user, i.e. the time needed to 
decompose, transfer, analyze and recompose data, starting with the spectra in mzXML file(s) on the 
user local computer and ending with the peptide identification in pepXML format stored in the same 
directory as the mzXML file. 
Table 4.1. Performance tests of the described method comparing elapsed time for 
analyzing multiple input datasets. 
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search, the used databases for the human serum and for E. coli datasets were 
retrieved from UniProt.39, 40 The spectral libraries for human and E. coli 
from National Institute of Standards and Technology (NIST) were used for 
the SpectraST searches.41, 42
Related Work 
Duncan et al. have developed a parallel version of a X!Tandem for Message 
Passing Interface  (MPI) enabled cluster.11 It is beneficial to run a search 
engine on a cluster using MPI in terms of speed; this demands anyhow the 
availability of an MPI enabled server/cluster to the scientist. Pratt et al.13
developed a cloud parallel peptide identification using parallel X!Tandem11,
Hadoop43, 44,  and MapReduce.45, 46 They used a similar approach to 
X!!Tandem12 in extending X!Tandem’s threading onto a network, but used 
Hadoop and MapReduce instead of MPI. Their implementation is meant for 
Amazon Elastic Cloud and they achieved speedup of 31-fold using 200 
Amazon cloud instances (corresponding to processing unit or a core). The 
current TPP version allows outsourcing X!Tandem searchs to Amazon 
Elastic Cloud to run multiple searches at the same time. We are not aware of 
any parallel implementation of SpectraST, but Baumgardner et al.  have 
recently implemented their own spectral library search algorithm for GPUs 
using CUDA.14 Our goal is to achieve data parallelism to accelerate peptide 
identification while preserving the search engine without any modification 
to its code. In principle, this makes the solution compatible also with closed-
source algorithms.  
RESULTS AND DISCUSSION 
The employed technologies can be divided into three categories: data 
decomposition, cloud computing and scientific workflow engines. Data 
decomposition/recomposition is the parallelization enabler. The virtual and 
physical computers in the cloud delivers the processing and storage power. 
Finally, scientific workflows are used to imbed the logic of the data analysis 
into interfaced processing steps, to scale analysis pipelines up to workflows, 
and to orchestrate the parallel processing. In the following we explain how 
we are leveraging these technologies in our implementation. 
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Data decomposition and recomposition algorithms 
Our decomposition algorithm splits an mzXML file into multiple smaller 
syntactically correct mzXML files. Syntactically correct here means that 
each daughter file is itself a valid mzXML file according to the mzXML 
schema.19 The requested number of daughter files is passed to the algorithm 
as an input. Typically, LC-MS or LC-MS/MS datasets incorporate many 
low quality (information-poor) spectra; particularly at the beginning and 
near the end of the chromatographic gradient, while the good (information-
rich) spectra are concentrated in the middle of the chromatographic run. 
Simply dividing the data in equal and sequential time intervals would 
therefore be suboptimal, as the early and late time intervals contains many 
spectra that would be immediately filtered out by the search engine. These 
data subsets would therefore process much faster than subsets from the 
middle of the gradient. To avoid this, we designed the algorithm to 
distribute the spectra from the original mzXML file randomly to all 
daughter files. This is an ad hoc approach to distribute good and bad spectra 
in order to divide the computational load evenly over the processing nodes. 
This also makes the method scaleable and independent on the 
chromatographic gradient and experimental design. Our data recomposition 
algorithm takes multiple pepXML files and composes them into one 
pepXML file. The algorithm takes into account the different original naming 
of the file and corrects the scan numbers to make the composed pepXML 
file schematically correct.20 Both algorithms are written in Java and are 
available on ms-utils.org/decomposition.  
Cloud computing 
We used a dedicated infrastructure for cloud computing at SARA.47 The 
infrastructure runs on OpenNebula cloud middleware. The 
instances/workers we used were minimal Ubuntu 11.04 server 64-bit virtual 
machines with Oracle (Sun) Java 6 build 1.6.0_26 installed. Depending on 
the workflow, a number of identical images can be initiated and used. For 
our tests we always used 8 instances, each of 8 virtual CPUs. Currently 
starting the workers from the workflow using OpenNebula Cloud 
Computing Interface services48 is not permitted due to the security policy of 
the provider. All necessary software to run a workflow, for instance the 
search engines, will be deployed on the target machine from within the 
workflow. This keeps the cloud instances lightweight and the workflows 
easier to update and adjust to the target cloud architecture. In case one 
4
Chapter 4 96
prefers another version of the search engine, or using a 32-bit server, only 
the corresponding executable has to be provided as an input to the 
workflow.
Scientific workflows 
The minimal workflow consists of three main processors: the mzXML 
decomposer, a search engine, and the pepXML composer (see Figure 4.1 
and 4.2). One extra processor is needed to uncompress (unzip) the 
downloaded data from the cloud. Moving compressed (zipped) data between 
the cloud and the local machine and vice versa reduces the latency regarding 
the network speed. This is very helpful when the data is in ASCII format 
and can be compressed down to 68% of its original size like in mzXML and 
pepXML formats. The NIST spectral libraries can be compressed down to 
32% of their original size. Each workflow processor includes the needed 
logic to run the corresponding program from the command line. The firing 
mechanism in Taverna is the availability of the data on the inputs of each 
processor. Taverna takes care of transferring the data between the 
processors. The data decomposing/recomposing processors are Beanshell  
Figure 4.1. A scientific workflow for searching LC-MS/MS mass spectrometry data using 
X!Tandem on the cloud. The workflow consists of 5 processors. The objectLogic processor 
prepares all inputs in the right format, i.e. keeping or converting strings into file object 
according to the following processor. The mzxmlDecomposer and pepxmlComposer run the 
decomposing/recomposing algorithms. objectLogic, mzxmlDecomposer and 
pepxmlComposer are Beanshell processors and they run locally. Xtandem runs X!Tandem 
on a remote machine and pepxmlUnzip unzip the pepXML files to a local directory; both 
are Tool processors. 
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Figure 4.2. A scientific workflow for searching LC-MS/MS data using SpectraST on the 
cloud. The processor mzxmlDecomposer, pepxmlUnzip and pepxmlComposer are identical 
to the one in the X!Tandem workflow (Figure 5.1). The only difference is that the Xtandem
processor is exchanged with the Spectrast processor and the constant inputs are adjusted to 
SpectraST. This approach is also possible for other search engines as described in the Data
decomposition and recomposition paragraph
processors and run locally. The search engine is a tool processor and runs on 
the cloud. Taverna stores the IP addresses and passwords of the cloud 
worker nodes in its credential management. The password repository is 
protected with a master password, i.e. the user need to authenticate only 
once when starting Taverna. 
Figure 4.1 shows a workflow to run X!Tandem on the cloud. The workflow 
takes the mzXML file(s), zipped search data base file in FASTA format and 
the number of the daughter mzXML files as inputs. Ideally the number of 
the daughter files is an integer factor of the available cloud workers. The 
search engine parameters are included in the runTandemExe processor. 
Figure 4.2 shows a simple scientific workflow to run SpectraST on the 
cloud. Similarly, the workflow takes the mzXML file(s), the zipped search 
library files (including the .splib, .spidx and .pepidx files) and the number of 
daughter mzXML files as inputs. SpectraST search parameters are included 
in the spectrastParameters processor, which is a string and is adjustable for 
different experiments. The processing logic of both workflows is very 
similar. The decomposition, recomposition and unzip pepXML processors 
are identical. The search engine calling processors are adjusted to each 
search engine, but are still logically very similar. This processor can be 
readjusted for other search engines. It is sometimes beneficial to separate 
the preprocessing/decomposing of the mzXML files from the logic of  
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Figure 4.3. An advanced scientific workflow for searching LC-MS data using SpectraST 
on the cloud. Uploading the libraries is optimized to achieve better performance, which 
makes this workflow more suitable for processing mzXML spectra files from human 
samples, as the corresponding NIST library needed by SpectraST is larger than 2 GB. Here 
we connect 3 nested workflows, in which the first 2, i.e. decomposeMzxml and 
uploadToCloud run in parallel while the third nested workflow, i.e. runSpectrastOnCloud
will start only if uploadToCloud finished all iteration. runSpectrastOnCloud and 
decomposeMzxml can still run in parallel. 
uploading big data like the NIST human spectral libraries41, 42 for 
SpectraST. Figure 4.3 illustrates an advanced workflow for SpectraST, in 
which the needed library and executables for the processing are uploaded 
simultaneously while decomposing the input mzXML files. The three 
workflows are available from ms-utils.org/cloud. 
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Speed performance comparison 
We compared the elapsed wall clock time needed to analyze one file of the 
human dataset, the whole human data set, and the whole E. coli dataset on a 
local workstation and on the cloud using our method. The results are 
summarized in Table 4.1 and Figure 4.6. In the simplest scenario of 
analyzing one mzXML file we achieved speedup of 11-fold in case of 
X!Tandem running on single core and of 6-fold in case of SpectraST. 
In order to exploit our implementation and test it for possible future big data 
challenges, we used spectra from fractioned sample to construct a single 
large mzXML file of 213,788 spectra. We profiled the number of cores in 
relation to the elapsed wall clock time needed to process these spectra and 
the results are illustrated in Figure 4.4. We were able to perform the peptide 
identification using X!Tandem and 8 cloud machines each of 8 processors 
within 12 min, a 26-fold faster than running it on a single core machine. 
When allowing phosphorylation as a variable modification, it was possible 
to obtain identical results within 72 minutes using 64 CPUs, or 5 hours on a 
single 8 CPU cloud node (comparable to an 8 CPU local machine). 
Figure 4.4. The wall time needed to 
search a large input file against a human 
sequence database40 as a function of the 
number of cores with only fixed 
modifications (solid, squares) and with 
phosphorylation as variable modification 
(dashed, diamonds).  By implementing 
data parallelism on the workflow level, it 
was possible to process 213,788 spectra 
in a 1.3 GB mzXML file with a search 
window of -0.5 to 2.5 Da in 12 minutes 
with only fixed modifications, a job 
which would take more than 5 hours on a 
desktop computer. When allowing 
phosphorylation (on serine, threonine 
and tyrosine) as a variable modification, 























To evaluate the performance in common practice, where the enzyme fidelity 
is not known a priori or other proteases may have been active, we ran a 
series of tests with semi-specific cleavage on a smaller set of 27,000 spectra 
and measured a 27-fold increase in speed (see Figure 4.5). When allowing 
three variable PTMs, the 64 CPU cloud finished searching these spectra 36 
times faster than a 4-core local machine. 
CONCLUSIONS
In data mining, data decomposition is considered the “most useful form of 
transformation of datasets”.49, 50 With our approach of wrapping data 
parallelism via decomposition and recomposition around the search engine, 
we were able to parallelize more than one peptide identification software. 
We demonstrated this using a common database search engine - X!Tandem 
- and a spectral library search engine - SpectraST. We achieved the 
parallelism by an ad hoc approach using off-the-shelf open source software 
for scientific workflow, i.e. Taverna workbench, and OpenNebula for cloud 
computing. We believe that such adhocratic cloud implementations can 
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Figure 4.5. Comparison of different 
search times with either variable 
modification or semi-specific cleavage 
(a). The X!Tandem workflow was used 
to search a human dataset of 27,436 
spectra against the human sequence 
database,40 with strict tryptic cleavage 
and allowing for phosphorylation 
(dashed gray, triangles), and with semi-
tryptic cleavage and only fixed 
modifications (solid gray, diamonds) as 
variable modification. Speed 
improvement of parallel processing in 
the 64-CPU cloud compared to 4 local 
CPUs of the same searches (b). 
a
b
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proteomics. A single large mzXML file of 1.3 GB containing 213,788 
spectra was searched using our cloud parallel X!Tandem in 12 min. 
Compared to other parallel implementation of search engines like the 
Message Passing Interface (MPI) enabled parallel X!!Tandem, or the 
Hadoop MapReduce deployment on Amazon web services – MR-Tandem, 
our method does not require dedicated MPI hardware or rewriting of the 
search algorithm. We designed our method to be generally applicable to any 
software that searches spectra independently and demonstrated this with 
X!Tandem and SpectraST. The method can possibly be used in combination 
with the other parallel programs. The decomposition/recomposistion 
algorithms and slightly modified workflows can then be used to distribute 
an mzXML file to multiple machines with the Hadoop MapReduce 
X!Tandem deployment or multiple machines with the MPI-parallel 
X!!Tandem. In this case the workflow can be modified to use the already 
installed search engine. In comparing speed performance by running 
identical searches on local machines and in parallel, our method achieved 
more than twice the increase in speed reported by the MPI-parallel 
X!!Tandem. Compared to the 31-fold speedup on 200 processors reported 
by the Hadoop MR-Tandem implementation, our method achieved 36-fold 
speedup on 64 processors. 
To make the implementation useful to the research community, we used 
common standards for input and output. Furthermore, cloud instances from 
providers like Amazon or in-campus clouds can be used as long as they are 
associated with public IP addresses. In such cases our implementation can 
be used without modification. Where the instances have private IP 
Figure 4.6. The performance of the cloud compared to local runs for the same search 
engines and data. Three experiments are compared, the details for which are listed in Table 
5.1.











Local run 1 CPU 11 16 12 44 50 46
Local run 4 CPUs 44 42 71
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One sample (human) 5 samples (human) 20 samples (E. coli)
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addresses, one can still launch the workflow from one of these instances 
without modification. Researchers can also build their own cloud 
environment by accessing accounts on different Linux machines without the 
need to install additional software; only Java is required, which is available 
for nearly all platforms. The decomposition and recomposition algorithms 
can be used in other scenarios, with or without clouds. For instance, when 
using a computer cluster or a computer with a multi-core CPU, the 
researcher can still use the data decomposition and recomposition with 
single-threaded algorithms such as SpectraST to gain parallelism.  
We are currently working with the developers of scientific workflow 
managers and cloud providers to address different issues including starting 
and shutting down the virtual machines on the cloud entirely from within 
the workflow, using certificates authentication, and enhancing the security 
on the cloud. We are convinced the 36-fold speedup reported here is still not 
exploiting the available resources to their full potential and also work to 
further improve the acceleration of these algorithms using cloud. 
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ABSTRACT
Background: Escherichia coli is a well-studied anaerobic bacteria which is 
able to regulate metabolic pathways depending on the type of sugar 
presented in the medium. We have studied the glucose-lactose shift in E.
coli at the protein level using a recently developed mass spectrometry 
platform. 
Method: Cells were grown in minimal medium containing two sugars 
(glucose and lactose) and analyzed using novel mass spectrometry cluster. 
The cluster combines the high resolving power and dynamic range of 
Fourier transform ion cyclotron resonance (FTICR) for accurate mass 
measurement and quantitation with multiple ion traps for fast and sensitive 
tandem mass spectrometry. The protein expression profile was followed in 
time across the glucose-lactose diauxic shift using label-free quantitation 
from the FTICR data. 
Results and Conclusion: The entire dataset was interrogated by KEGG 
pathway analysis, mapping measured changes in protein abundance onto 
known metabolic pathways. The obtained results were consistent with 
previously published gene expression data, with β-galactosidase being the 
most strongly induced protein during the diauxic shift.  
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INTRODUCTION
Bacteria, such as Escherichia coli, provide “simple” biological models due 
to a relatively small genome/proteome size (less than 5,000 genes/proteins) 
and are easy to culture. When the growth medium is rich in glucose, E. coli 
uses glycolysis to convert glucose into pyruvate, requiring adenosine 
diphosphate (ADP) and oxidized nicotinamide adenine dinucleotide (NAD+) 
as cofactors. But E. coli is also able to use many other sugars, including 
lactose, as the main carbon source.1 The genetic mechanism of metabolic 
switch from glucose to lactose was first described in the pioneering work of 
Jacob and Monod fifty years ago.2 The operon model that they suggested3 
can be described as follows: In the absence of any regulation, the expression 
of three structural genes (lacZ, lacY, lacA) is inhibited by a repressor 
molecule, the protein product of lacI gene. If present, lactose is taken up 
from the medium and allolactose, formed from lactose, releases the 
repressor from the operator. In absence of glucose, cAMP concentration is 
high and cAMP binds to the catabolite activator protein (CAP), allowing the 
latter to bind to the promoter and initiate mRNA synthesis. This kind of 
double control causes the sequential utilization of the two sugars in discrete 
growth phases. According to this model, the operator region is not essential 
for operon activity, but rather serves as a controlling site superimposed on a 
functioning unit.4 
While previous studies were focused on discovery of genetic mechanisms of 
metabolic switches, we used a new label-free proteomic approach to study 
the dynamics of protein expression during the metabolic switch. Proteomics 
is a powerful and rapidly developing field of research, increasingly 
expanding our detailed understanding of biological systems.  It can be used 
in basic studies on protein dynamics, localization, and function5 but also to 
discover potential biomarkers for diseases and response to pharmaceuticals.6 
Proteomics aims to be comprehensive - quantifying “all” proteins present in 
an organism, tissue or cell. This is a non-trivial task, as there are no 
amplification methods akin to the polymerase chain reaction available, and 
proteins in a complex sample typically vary over many orders of magnitude 
in concentration. Common solutions to overcome this problem include 
fractionation of proteins, e.g. by SDS-PAGE7 or chromatography, and 
depletion of abundant proteins.8, 9 The accurate quantitation of changes in 
protein expression in or between different samples or states is one of the 
primary objectives in proteomics.10 Several methods for labeling proteins 
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metabolically (in cell cultures) or after extraction are widely applied in 
“shotgun” proteomics. The labels either incorporate heavy, stable isotopes 
or a fluorescent group. Nonetheless, it is also possible to quantify peptides 
and proteins in individual samples directly from the mass spectrometer 
signal, the so-called “label-free” quantitation. This type of quantitation 
demands reproducible sample preparation and protein digestion, and 
benefits from using a mass spectrometer with a wide dynamic range and 
resolving power, such as an FTICR instrument. Despite these prerequisites, 
label-free quantitation holds a few advantages over the use of labels. For 
instance, the sample workup procedure is simpler as there is no labeling 
step, and the number of samples is not in any way limited by number of 
labeling reagents and can be used in large studies or for analyzing a large 
number of time points. Methods based on labeling, on the other hand, have a 
built-in maximum number of samples that can be analyzed in parallel, 
beyond which multiple analyses has to be made by bridging between them 
(which requires one sample or reference to be shared between at least two 
analyses). Label-free methods seek to reduce potential interferences, for 
instance by increasing resolving power, and improving accuracy, e.g. 
through data normalization.11 In our study we used a novel FTICR-ion trap 
cluster which combines the high mass accuracy of FTICR with fast and 
relatively inexpensive ion traps for MS/MS12 making it ideally suited for 
large-scale, label-free proteomic studies. 
MATERIALS AND METHODS 
Escherichia coli Glucose-Lactose Diauxie Experiment
Previous work has shown that glucose-lactose diauxie involves activation of 
the lac operon and high expression of β-galactosidase, but also of many 
other genes and proteins. To compare with gene expression data we 
reproduced the experiment of Traxler et al. using E. coli K12 strain 
MG1655 (ATCC® Number 47076, ATCC, Manassas, VA, USA); this strain 
was grown overnight in 25 mL Luria-Bertani (LB) medium in 50-mL 
Falcon tubes. When optical density at 600 nm (OD600) reached 5.0, the cell 
culture from each Falcon tube was spun down in an Eppendorf 5810 
centrifuge at 194×g and 37°C. The supernatants were removed, the pellets 
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resuspended in warm (37°C) sterile PBS, pooled together and spun down 
again with the same parameters. After the PBS was removed, 10 ml of 1X. 
MOPS minimal medium (Teknova, Hollister, CA, USA) was added and the 
OD600 measured. This culture was then used to inoculate a 3-L bioreactor 
(Applikon, Schiedam, Netherlands) with 1 L 1X MOPS minimal medium 
containing 0.5 g/L glucose and 1.5 g/L lactose as the only carbon sources. 
The temperature was kept at 37°C, dissolved oxygen maintained above 20% 
and the growth of cells monitored by sampling 1.5 mL of culture for OD600 
measurement. The concentration of glucose and lactose were assayed using 
enzymatic kits (Sigma-Aldrich, St. Louis, MO, USA and BioVision, 
Mountain View, CA, USA, respectively). Samples were drawn from the 
culture every 30 minutes before and after diauxie and every 10 minutes near 
and during the diauxic shift. Cells were spun down at 4°C and 3,500 rpm, 
transferred to a fresh tube and frozen at -20°C. After collection of all time 
points, all pellets were thawed, rinsed with ice cold PBS, transferred to a 
1.5-mL Eppendorf tube and spun down again for 10 min on maximum speed 
(16,100×g) at 4°C. 
Protein Extraction, In-solution and In-gel Digestion 
The pellets were weighed and 5 mL of the BugBuster® Master Mix 
(Novagen, Merck KGaA, Germany) was added per gram cell paste. Cells 
were incubated at room temperature on a shaking platform at slow settings 
for 20 min. After the insoluble cell debris was removed by centrifugation at 
16,100×g for 20 min at 4°C, the supernatant was transferred to a fresh tube. 
Proteins extracted from the pooled sample of one early and one late time 
point were used for SDS-PAGE protein separation and in-gel digestion for 
peptide and protein identification. The rest of the proteins were used for in-
solution digestion and peptide and protein quantitation. The extracted 
proteins for each time point and replicate were digested using trypsin. To 
each 50 µL of protein extract (approximately 0.25 mg protein) 10 µL 60 
mM DTT in 25 mM ammonium bicarbonate (ABC) was added, followed by 
incubation for 45 min at 56°C to reduce cystines. After 45 minutes, 100 mM 
iodoacetamide (IAA) in ABC was added to a final IAA concentration 25 
mM and the samples kept in dark for 1 h at room temperature to alkylate 
and protect the cysteins. The proteins were then digested for 5 hours at 37°C 
by adding 10 µL 100 ng/µL sequencing-grade trypsin (sequencing grade, 
Promega, Madison, WI, USA) in ABC. The digestion was quenched by 
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adding 5 µL 10% TFA to lower the pH. The peptide digests were stored at
-20°C until analysis.
For MS/MS peptide identification, 25 µg of proteins from two time points, 
one before and one after the diauxic shift, were fractionated using 8-12 % 
acrylamide SDS-PAGE (NuPAGE™ 8-12%, Invitrogen, Carlsbad, CA, 
USA). The gel was stained overnight (12 h) in staining solution (Invitrogen) 
with 5% methanol and was then washed with milli-Q water until cleared. 
The gel lanes were cut into twenty-six 2 mm bands and transferred to 96-
well plate. Each band was de-stained using 25 mM ABC and acetonitrile, 
reduced (75 µL 10 mM DTT, 56°C, 30 minutes), alkylated (75 µL 55 mM 
iodoacetamide, room temperature, 20 min in dark) and digested in-gel using 
trypsin (20 µg in 20 µL) 12 h at 37°C. The supernatant from each well was 
transferred to a fresh plate. The digestions were quenched by adding 4 µL 
5% TFA (first extraction). The gel pieces  were then incubated for 1 hour at 
37°C in 0.1 % TFA, after which the second supernatant was pooled with the 
first extraction and frozen. 
FTICR – Ion Trap Cluster 
The novel FTICR – ion trap cluster12 consists of a refrigerated solariX™ 12 
T FTICR (Bruker Daltonics, Bremen, Germany) and six ion traps. In this 
study, CID data from an HCT ultra ion trap (Bruker Daltonics) was used for 
peptide identification by MS/MS. All mass spectrometers in the cluster were 
coupled on-line to parallel, splitless NanoLC-Ultra 2D plus systems 
(Eksigent, Dublin, CA, USA) with additional loading pumps for fast sample 
loading and washing, which resulted efficient use of the mass spectrometers 
and high chromatographic peak capacity. All LC systems were configured 
with 15-cm 300 µm-i.d. ChromXP C18 columns supplied by Eksigent and 
linear 90 minute gradients from 4 to 44% acetonitrile in 0.05% formic acid 
were applied. The LC systems were controlled by HyStar 3.2-3.4 with a 
plugin from the LC manufacturer, the ion traps by esquireControl 6.2 and 
the FTICR by apexControl 3.0, all from Bruker. The acquired data from 
each mass spectrometer was automatically transferred to a dedicated server 
and processed as described below. 
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Figure 5.1. Data processing workflow. The data obtained from the FTICR-ion trap cluster 
was processed using the workflow illustrated here. First, the LC-MS/MS datasets from the 
ion trap were searched against the Escherichia coli protein sequence database using 
Mascot. Each individual result was aligned to a single master LC-MS dataset and then 
merged into one file with aligned retention times. Each separate FTICR LC-MS dataset was 
aligned against the merged LC-MS/MS data (and hence the master FTICR dataset). 
Intensities of the identified peptides were then extracted from each FTICR LC-MS dataset 
by taking the maximum signal in a window of defined m/z and retention time relative to the 
identified peptide. The resulting list contained the protein name, peptide sequence, 
maximum observed ion score, and absolute intensities for each peptide. This information 
from each sample could then easily be collapsed into a single, uniform sample/data matrix 
with the total absolute intensities for all identified proteins and samples.


















































































































Each individual MS/MS dataset provided by the ion traps was converted to 
MGF files using DataAnalysis (Bruker Daltonics). The datasets were 
separately searched using Mascot 2.1 and converted to the pepXML13 
format. Using the identified peptides, each LC-MS/MS dataset was aligned 
against a master FTICR LC-MS dataset using msalign14 and merged. All 
identified peptides with a best Mascot ion score of at least 25 were then 
aligned against each individual FTICR LC-MS dataset, one for each 
biological replicate and time point. Using these alignments, the peaks 
corresponding to the identified peptides were integrated over the duration of 
the chromatographic peak. The data analysis workflow is illustrated in 
Figure 5.1. Only peptide identifications confirmed by accurate mass 
measurement were thus used. The peptides were then grouped into proteins, 
using only peptides attributable to a single protein, and the sum of all 
peptide intensities used as a measure of protein abundance. The data was 
normalized against the most abundant protein and the earliest time point. 
The resulting relative protein intensities were log2–transformed and 
visualized using the gplots package in R. In the same package we created 
hexadecimal color codes corresponding to the average values over all 
expression ratios for each protein. An expression ratio of +2.5 thus 
corresponded to #00FF00, 0 to #FFFF00 and -2.5 to #FF0000. The color 
codes were then mapped onto metabolic pathways available in the Kyoto 
Encyclopedia of Genes and Genomes (KEGG).15 
RESULTS AND DISCUSSION 
The glucose-lactose diauxie is a classical Escherichia coli experiment which 
has been repeated many times, including recent studies on gene expression 
using microarrays.16 In our experimental setup, the growth rate and glucose 
concentration allowed precise determination of onset of glucose-lactose 
(Figure 5.2). The onset of diauxie occurred when cell suspension reached 
OD600 of ~0.6 or a density of approximately 5×108 cells/mL.17 This was 
reproducible in each experiment (OD600 of 0.64, 0.60, and 0.55 
respectively) and the OD600 could be used as a predictor during the 
experiment to optimize the sampling of the culture before and during the 
diauxic shift. The cell density at the onset of diauxic shift was 
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Figure 5.2. Measured cell growth 
(OD600, solid) and glucose 
concentration (dashed) in one glucose-
lactose diauxie experiment. The onset of 
the diauxic shift is easily determined 
from the 20-30 minute plateau in the 
growth curve, which coincides with the 
depletion of glucose in the medium. 
After about +200 minutes, both sugars 
are exhausted and the growth stops 
(OD600max = 2.2-2.4). 
 
Figure 5.3. Glucose-lactose diauxie 
protein expression. The proteins 
expressions were visualized using R and 
clustered in three groups (green – 
upregulated , red – downregulated, gray 
– no change). For subsequent analyses, 
the time scales of all replicates were 
aligned with time t = 0 at the observed 
onset of diauxic shift. 
approximately one quarter of the final density, which is consistent with 
previous observations, and depends on the glucose-lactose ratio 18. The time 
scales for all protein expression measurements could thus be aligned to the 
growth curve for each replicate culture experiment, facilitating 
discrimination consistent observations and measurement noise. From the 
LC-MS/MS data of 52 SDS-PAGE slices, 4,333 peptides from 948 proteins 
were identified (see the additional file 1) with a false discovery rate of 
6.75% of the peptide level (Figure 5.3). During the diauxie, we observed 
rapid changes in protein expression (see the additional file 2). However the 
magnitude of those changes was not as drastic as gene expression. 
Comparing with the publicly available gene expression data from Traxler et
al.,16 many similar expression patterns can be recognized, especially for 
strongly upregulated genes/proteins. Not surprisingly, β-galactosidase 
expression increased strongly, almost 16-fold, during diauxic shift and 
followed the dynamics of gene expression (Figure 5.4) with a small lag 
expected by the delay between gene activation and accumulated protein. 
The genetic response occurred immediately after glucose exhaustion but 
protein synthesis is typically delayed between 20 seconds and several 
minutes in E. coli.3 Small relative changes in concentration of already 
























































0-90 -60 10 20 30 40 60 90
5
Figure 5.4. Expression of lacZ and 
malE. mRNA (dashed) and protein 
(solid) dynamics for periplasmic 
maltose-binding protein/malE (black) 
and β-galactosidase/lacZ (gray) 
upregulated during glucose-lactose 
diauxie (time 0). 
accumulated for some time before they can be observed. Nevertheless, we 
noticed that the most significant changes in protein abundance took place 
within 40 minutes after onset of diauxic shift, which is consistent with 
published gene expression data and the observed resuming of growth. Since 
the gene expression data was derived from that published by Traxler et al., 
the alignments of the time-scales are not perfect and minor discrepancies 
between the sampling of the gene and protein expression could be expected. 
The protein expression measurements were with a few exceptions 
reproducible, albeit not always in perfect agreement with the published gene 
expression data. This could be explained by noise in the data and the fact 
that gene and protein expression were not measured in the same cell culture. 
For instance, the change in gene expression of malE is almost the same as 
for lacZ, but at the proteomic level we observed only slight changes in 
abundance of the maltose-binding protein coded for by malE (Figure 5.4). 
(The maltose-binding protein is a periplasmic component of the maltose 
ABC transporter which is capable of transporting malto-oligosaccharides up 
to seven glucose units long.19) 
Using the clustering function for large datasets, clara, from the R cluster 
package20, the dataset could be broadly divided into groups of up- and 
downregulated proteins, along with proteins that do not change measurably 
as a function of the diauxic shift. The FTICR-ion trap cluster provided 
comprehensive label-free quantitative proteomic data with sufficient 
throughput for an arbitrary number of conditions or time points and 
biological replicates (here about 30), allowing a global study of protein 
expression dynamics in E. coli. With this instrument platform, proteomics 
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Figure 5.5. The protein expression profiles mapped onto the galactosidase metabolic 
pathways highlights changes in metabolism when shifting from glucose to lactose as 
primary carbon source. The measured changes in enzyme (protein) abundance were 
converted to color and mapped onto KEGG pathways. Upregulated proteins are marked in 
green, downregulated in red, and unchanged in yellow. 
To illustrate changes in metabolic pathways, the protein expression data was 
mapped onto KEGG metabolic pathways and changes in level of expression 
indicated by color (Figure 5.5). Most proteins in the same pathways as β-
galactosidase were also markedly upregulated, leading to a global activation 
of the galactose pathway responsible for channeling lactose into the 
glycolytic pathway. Other metabolic pathways changed to a lesser degree, 
as measured by protein (enzyme) abundance. 
CONCLUSIONS
We have reproduced the textbook glucose-lactose diauxie experiment in E.
coli using a state-of-the-art method for quantitative proteomics using a 




three experiments the onset of diauxie occurred at approximately the same 
cell density and the duration of diauxic shift was also similar. The identified 
and individually quantified peptides were collected into quantitative protein 
measurements, which were visualized and compared using tools developed 
in-house. Through kind assistance from KEGG it is now possible to upload 
color codes for a whole list of quantified proteins on any metabolic pathway 
overview (the R program for generating the color codes from protein 
abundance ratios is available from the authors). We could confirm that the 
most strongly induced enzymes belong to the pathway responsible for 
glucose and lactose metabolism. 
The FTICR-ion trap cluster in combination with the appropriate 
visualization tools makes an efficient approach for investigation of protein 
expression dynamics. The new instrument configuration and software 
proved robust in acquiring and processing data, allowing label-free 
quantitation of ~1,000 identified proteins over ~30 time points in a 24 h 
measurement. Furthermore, the high dynamic range and resolving power of 
FTICR made label-free quantitation accurate and precise, at least for a label-
free method.21 Finally, as expected, key aspects of the proteome dynamics 
were indeed bound to reflect gene expression under the glucose-lactose 
metabolic switch.
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Directed differentiation of human pluripotent stem cells (hPSCs) to 
specialized cell types opens new possibilities for tissue replacement in 
regenerative therapies. Although efficient protocols have been developed to 
generate cardiomyocytes in vitro, much remains to be learned about the 
changes that take place in the transcriptome, proteome and methylome of 
the differentiating cells. Studies aimed at deciphering these dynamic 
changes during differentiation will lead to better understanding of the 
multiple events involved in this process. With rapidly increasing sensitivity 
and speed of mass spectrometry, large-scale, spatiotemporal analyses of the 
proteome are becoming feasible. Here, we show how a fast and simple 
sample preparation method can be used to obtain enriched subcellular 
fractions. Combined with samples collected at different stages of 
differentiation, the changes in the proteins can be studied in the context of 
their localization and expression dynamics. In total, we identified 41,626 
peptides from 6,936 proteins over four time points and five subcellular 
localizations. Known cardiomyocyte markers were identified, and proteins 
associated with motor and structural activity increased over time, including 
known proteins responsible for cell-cell communication and contractile 
properties. We describe a method and scientific workflow to analyze, 
visualize and browse the data, incorporating mass spectrometry and gene 




Human embryonic stem cells (hESC), derived from the inner cell mass of 
blastocyst-stage embryos, have the capacity to self-renew indefinitely and to 
differentiate to all cell types of the human body1. In the presence of the 
appropriate signaling cues ESCs can form tissues of all three primary germ 
layers2 and all types of somatic cells in vitro and in vivo3, 4 In recent years, 
detailed differentiation protocols have been developed for the production of 
specialized cell types in vitro. However, many details of the differentiation 
process are still unclear and identification or isolation of specific (subtype) 
cell populations is challenging. A better understanding of the different steps 
during stem cell differentiation may lead to a better control of the 
differentiation process and to a potentially unlimited source material for 
tissue replacement in regenerative therapies5. This is even more relevant 
following the demonstration of the groundbreaking technology for 
reprogramming human (patient-derived) somatic cells to induced 
pluripotent stem (iPS) cells,6 which share similar properties with ESCs. 
Recently, several groups, including ours, have reported defined 
differentiation protocols leading to efficient cardiomyocyte production 
using human ESC end iPS cells.7 In general, stage-specific modulation of 
different proteins, such as Activin A, Bone Morphogenetic Protein (BMP) 
and Wnt, are important for consistent and efficient production of functional 
cardiomyocytes,8, 9 which are phenotypically and electrophysiologically 
comparable to  primary human fetal cardiomyocytes in culture.10
Although whole genome transcriptome analysis of various stages during 
cardiomyocyte differentiation of hESC has been performed,11 studies of the 
human proteome of hESC during cardiomyocyte differentiation are either at 
very early stages of differentiation or in hESC-derived cardiomyocytes.12, 13
The level of mRNA expression cannot be directly correlated with amount of 
the protein it codes for, due to post-translation regulation, post-translation 
modification, protein export or degradation. In addition, gene expression 
information is very hard to interpret in terms of biochemical function, 
structure and subcellular localization of its protein product and mostly 
derived from in silico prediction models. Quantitative spatially and 
temporally resolved proteomics enables us to gain insight into the 
mechanisms driving the differentiation towards a specific cell type. 
Differentiating ESCs undergo massive transformations in the proteome on 
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their path to mature cardiomyocytes in order to alter their metabolism and 
drastically change their morphology, including the synthesis and assembly 
of sarcomers, the smallest contractile units of cardiomyocytes. Most 
regulatory proteins exist in cells at low concentrations and are localized at 
very specific subcellular compartments. Additionally, due to the high 
complexity of eukaryotic cells, extra fractionation step is commonly 
beneficial for the whole proteome studies. Here, we couple simple 
organellar fractionation with standard proteomics techniques, which allow 
us, in principle, to measure and follow changes in protein distribution by 
quantifying proteins in individual organellar fractions separately. 
One of the major challenges here, especially for label-free proteomics, is the 
separation of enriched subcellular partitions (cytosol, cytoskeleton, 
membranes, nucleus and nucleolus) from a limited number of cells in a 
reproducible manner. To analyze enriched bur not necessarily pure 
fractions, additional computational and statistical tools may be needed. In 
this work we describe a simple protocol for sample preparation for label-
free spatiotemporal proteomics in hESC differentiating towards the cardiac 
linage, including an automated workflow to analyze and visualize the 
results. 
MATERIALS AND METHODS
Cell cultivation, collection and protein extraction 
For differentiation of human pluripotent stem to the cardiac lineage we used 
a previously described a cardiac reporter line, hESC Nkx2.5-GFP, which 
expresses GFP under control of the cardiac transcription factor Nkx2.5.8 At 
different stages during differentiation we collected cells for protein 
extraction. For cardiomyocyte differentiation cells were resuspended in 
defined differentiation medium containing BPEL and a cocktail of growth 
factors BMP4 (20 ng/mL), Activin A (20 ng/mL), VEGF (30 ng/mL) and 
SCF (40 ng/mL) and plated at a density of 3000 cells per well in V-shaped 
96-well plates. After 3 days cells were washed in BPEL only and after 7 
days cell aggregates (so-called embryoid bodies) were plated on matrigel-
coated wells.8 Cells were collected at different time points (0, 3, 7, and 15 
days) recapitulating different embryonic/cardiac developmental stages. Day 
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0 represents the “pluripotent undifferentiated” stage, day 3 “mesoderm”, 
day 7 “cardiac progenitor” and day 15 “beating cardiomyocyte” stages. For 
collection of cells, medium was removed following centrifugation (3 min at 
100×g) and, washed twice with PBS, and stored at -80°C.  Proteins were 
isolated following cell lysis in 1% SDS in a hot (70°C) ultrasonic bath 
(VWR Ultrasonic Cleaner) for 2×10 min. To remove DNA, the protein 
extract was incubated on ice 15 min with 12.5 U benzonase (Novagen, 
Merck KGaA, Darmstadt, Germany) in presence of 2 mM MgCl2. Thirty µg 
of proteins of  each sample (bicinchoninic acid (BCA) protein assay kit; 
Thermo Fischer Scientific, Waltham, MA) was diluted in water and 4x LDS 
running Buffer (Invitrogen, Carlsbad, CA) for SDS-PAGE. 
Subcellular fractionation 
For the organellar fractionation 106 cells (equivalent to 30 µg of protein in 
total cell extract) we used Subcellular Protein Fractionation Kit for Cultured 
Cells (Thermo Fischer Scientific). From the day 7 time point, collected cells 
were first resuspended in ice-cold Cytoplasmic Extraction Buffer and 
incubated on ice for 10 min. Cytoplasmic fraction was separated by 
centrifugation at 500×g for 5 min and supernatant was collected to a fresh 
pre-chilled tube. Obtained pellet was mixed with Membrane Extraction 
Buffer and vortexed for 5 sec. After the incubation on ice for 10 min the 
sample was centrifuged at 3,000×g for 5 min, the membrane extract was 
transferred to a fresh pre-chilled tube. Subsequently, the nuclear fraction 
was acquired by incubation of the remaining pellet with Nuclear Extraction 
Buffer on ice for 30 min and further centrifugation at 5,000×g for 5 min. 
The same buffer containing 100 mM CaCl2 and Micrococcal Nuclease was 
used to extract chromatin-associated proteins. Finally, Pellet Extraction 
Buffer was added to the remaining sample and incubated for 10 min at room 
temperature. The supernatant after centrifugation at 16,000×g for 5 min 
containing cytoskeletal extract was transferred to a new tube. To prevent 
protein degradation all buffers contained Protease Inhibitor Cocktail 
(included in the kit). Resulting fractions (approximate protein content 3-5µg) 
 were lyophilized and reconstituted in 15 µL of water and diluted with 5 µL
 4x LDS running Buffer (Invitrogen) for SDS-PAGE. 
SDS-PAGE and in-gel digestion 
Each sample was loaded on a 1 mm 10x well 4-12% NuPAGE® Bis-Tris gel 
(Invitrogen) and separated for 1 h at 180 V. The gel was stained in 
NuPAGE® Colloidal Blue (Invitrogen) overnight on the shaking platform at 
6
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room temperature and distained with milli-Q water until cleared. Each lane 
was cut into 48 identical 1.5×5-mm slices using a MEE1.5-5-48 disposable 
gel cutter (Gel Company Inc., San Francisco, CA) and placed into a 96-well 
polypropylene PCR plate (Greiner Bio-One, Frickenhausen Germany). The 
gel pieces were distained using consecutively 25 mM ammonium 
biocarbonate (ABC) and 100% acetonitrile. DTT reduction and IAA 
alkylation were performed according to the previously published protocol.14
In-gel tryptic digestion was done in 30 µL of 25 mM ABC containing 5 
ng/µL trypsin (sequencing grade, Promega, Madison, WI) for 6 h at 37°C. 
The resulting peptides were extracted with TFA according to the previously 
described protocol.14
LC-MS/MS analysis
The analysis was performed using a splitless NanoLC-Ultra 2D plus 
(Eksigent, Dublin, CA) for parallel ultra-high pressure liquid 
chromatography (UHPLC) with an additional loading pump for fast sample 
loading and desalting. The UHPLC system was configured with 300 µm-i.d. 
5-mm PepMap C18 trap columns (Dionex, Sunnyvale, CA) and 15-cm 300 
µm-i.d. ChromXP C18 columns (Eksigent). Peptide separation was 
performed running 90 min linear gradients from 4 to 33% acetonitrile in 
0.05% formic acid. The UHPLC system was coupled on-line to an amaZon 
ETD speed high-capacity 3D ion trap with the standard 2-50 µL/min 
electrospray source (Bruker Daltonics, Bremen, Germany). After each MS 
scan, up to ten abundant multiply charged species in m/z 300-1300 range 
were automatically selected for data-dependent MS/MS but excluded for 
one minute after being selected twice. The LC-MS/MS system was 
controlled using HyStar 3.4 with an Eksigent plug-in and trapControl 7.0, 
all from Bruker. 
Data analysis
All acquired tandem mass spectrometry data was processed in one batch 
using Taverna workbench.15 The workflow (Figure 6.1) converts raw data 
.yep files to mzXML16 using compassXport 3.0.5 (Bruker) and passes this, 
along with the sequence database to SpectraST in the Trans-Proteomic 
Pipeline (TPP).17 The NIST human spectral library from 2011-05-26 was 
searched with default settings except for allowing carbamidomethylation 
(“CAM”) of cysteines. Search results in pepXML17 format were then fit by 
a mixture model and the SpectraST discriminant score converted to  
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Figure 6.1. Taverna scientific workflow 
for downloading GO information and 
visualization of protein expression over 
time and as function of subcellular 
fraction. The workflow also compares 
measured with predicted protein 
localization and calls goa_gubbar to 
summarize the protein spectral counts in 
gene ontology categories. The output 
result table with the whole list of 
identified proteins and their localization 
is presented in the supplementary 
material. 
probability for each peptide-spectrum match by PeptideProphet18. Results 
were reported with 2% FDR and for each protein identification its relative 
abundance was calculated based on the spectral count. The 
identifications/abundance table was then passed to an Rshell script where it 
was analyzed, comparing the spatial distribution of each protein with 
protein localization from a gene ontology annotation database 
(http://www.ebi.ac.uk/QuickGO/). However, the obtained fractions were 
impure due to imperfect fractionation or protein trafficking and to remove 
the possible bias the data from each organellar was first normalized against 
6
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total spectral count. For each protein the data was anew normalized across 
the maximum spectral count per protein, creating the distribution between 0 
and 1 which was then converted to a color intensity and mapped onto a 
symbolic representation of the cell with only these subcellular 
compartments. Two instances of such representations can combine all 
protein measurements and the protein localization from gene ontology and 
included in tables for browsing the data on the protein level, similar to 
ProteinProphet in the TPP. Gene ontology information for all or specific 
subsets of the identified proteins and their corresponding spectral counts 
were summarized using the goa_gubbar tool (http://www.ms-
utils.org/goa_gubbar/index.html).19
RESULTS AND DISCUSSION 
Time-resolved proteomics 
The aim of this study was to develop a fast, simple and high-throughput 
organellar fractionation method to generate a library of peptide 
identifications. Secondly, to establish a simple computational tool to 
analyze, combine and visualize the multidimensional data and thirdly to 
apply this technology at various stages of hESC differentiating to 
cardiomyocytes. To demonstrate feasibility of the spatiotemporal 
proteomics, two experiments were performed separately. The mass 
spectrometric analysis methods have been described previsouly14 and are 
based on LC-FTMS and label-free quantitation of peptides identified by 
MS/MS in separate ion trap measurements, similar to the accurate mass and 
time method20 and Corra.21 From the collected undifferentiated pluripotent 
stem cells at day 0, early mesodermal cells  at day 3, cardiac progenitor 
cells at day 7 and functional beating cardiomyocytes at day 15. Over all 
time points we identified 39,067 peptides and 5,184 proteins with 2% FDR 
on the PSM level and approximately similar number of identified 
peptides/proteins per sample (see Figure 6.2a and supplementary material). 
By simple spectral count, we observed known sarcomeric proteins induced 
at the later stages, when cardiomyocytes display contractile activity and are 
to express high levels of these proteins (Figure 6.3). As expected, proteins 
involved in motor activity/contractility or cytoskeletal architecture are 
present in higher abundancy at day 7 and 15 (Figure 6.4). The functional 
classification of proteins was here based on the gene ontology “slim” terms, 
with myosin being the major contributor to the motor and structural 
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Figure 6.2. SpectraST search results per 
time point (a) and per organellar (b) in 
number of identified peptides and 
proteins. 
molecular activity. Laminin, the protein responsible for intercellular 
communication and unified contraction in cardiomyocytes,22 was also found 
upregulated. However, translation regulator activity decreased with time, 
finding is not unexpected, given that mature cardiomyocytes are tightly 
interconnected via gap-junctions and have only limited motility. At day 7 of 
differentiation, GFP fluoresence, representing activity of the transcription 
factor Nkx2.5, is visible for the first time. At this stage immature 
cardiomyocytes or cardiac progenitors are present. 
Organellar proteomics 
Subcellular fractionation is a classical sample refinement method and a wide 
range of protocols and several commercial kits are available. At first the 
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Figure 6.3. Protein expression of the 
cardiomyocyte markers (actinin – 
P12814 and myosin – P13533) based on 
the absolute spectrum count per protein.
Figure 6.4. Functional distribution of 
proteins during cardiomyocyte 
differentiation. Proteins are grouped 
based on the GeneOntology “slim” terms 
using goa_gubbar tool. The relative 
abundance is calculated as the percent of 
total spectral count. 
keep the membranes intact or homogenized in presence of more aggressive 
reagents and then fractionated by ultracentrifugation into different 
populations of organelles. However, different populations share similar 
physical properties and cosediment to some extent. Although these 
organellar fractions are not absolutely pure, they are highly enriched in the 
targeted organelle. By measuring all fractions of a cell, it is possible to 
account for all of the protein and determine where a particular protein is 
most abundant. This information then either supports or contradicts 
predicted or previously observed functions and interactions of that protein. 
If applied to data from several time points, the obtained information enables 
us to trace the protein dynamics in time as well as in space, producing two-
dimensional expression matrix for each protein. 
The availability of starting material (cells) is often limiting the use of 
classical methods such as homogenization followed by ultracentrifugation in 
a sucrose gradient. We used a simple commercial kit directly compatible 
with SDS-PAGE, thereby avoiding buffer exchange with concomitant 


















































Figure 6.5. Organellar enrichment 
relative to the experimental cytoplasmic 
extract compared to the GeneOntology-
derived protein localization (a) and the 
protein content of the membrane extract 
(b). 
approximate information on protein abundancy. From one time point (day 
7) across five cellular components 31,023 peptides from 4,264 proteins were 
identified (with 2% FDR on the PSM level). Not surprisingly, the number of 
identified peptides/proteins varied greatly between subcellular fractions 
(Figure 6.2b and supplementary material). To determine the quality of the 
partitioning, we compared measured localization with that from gene 
ontology (Figure 6.5a). The changes are expressed relative to the 
cytoplasmic fraction, as this is collected first and contains some material 
derived from all other cellular compartments as well as the extracellular 
matrix. The membrane extract is strongly enriched with known or predicted 
membrane proteins compared to all other fractions, and also includes many 
endoplasmic reticulum and mitochondrial proteins (Figure 6.5b). The 
ontological protein localization patterns in the nuclear and chromatin-bound 
nuclear extracts were similar, and strongly enriched in nuclear and 
chromosomal proteins. However, the gene ontology vocabulary does not 
correspond to mutually exclusive categories and is often imprecise. For 








































cytoskeletal fraction is collected last and is enriched in structural proteins, 
most of which are annotated as cytoplasmic, and contains less membrane 
and nuclear proteins than the initially collected cytoplasmic fraction. 
Despite its obvious shortcomings, this simple gene ontology breakdown 
may be useful for comparing and optimizing subcellular fractionation 
methods. 
Spatiotemporal proteomics 
In this preliminary work we only included by one trace along the temporal 
and one trace along spatial axes. In general, and in future studies, both 
variables will be varied, producing an abundance matrix for each protein (or 
protein). For browsing such data, it would be beneficial to analyze and 
simultaneously visualize spatial and temporal aspects of the data – here the 
subcellular localization and time point. By translating the protein abundance 
into a color code and map it to a simplified but intuitive graphical 
representation of a cell, the data can be visualized statically (Figure 6.6). 
 The protein expression dynamics can be visualized by a series of such 
glyphs, or as an animation, for instance as embedded animated PNG images, 
which can also be generated by R from within a Taverna workflow. This 
provides a primitive, protein-level browser for inspecting individual 
proteins or groups of proteins. Links to other, freely available, resources 
with information on protein localization, such as ProteinAtlas 
(http://www.proteinatlas.org) can then be used to compare findings from the 
proteomics experiment with high-resolution immunohistochemical 
microscopy for that protein, bridging mass spectrometry and affinity based 
proteomics. 
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CONCLUSIONS
The ability of hESCs to differentiate into all cell types provides many 
possibilities for clinical applications. However, the lack of detailed, 
molecular information on changes in the proteome during differentiation 
still limits our understanding of the underlying mechanisms and processes. 
In this work we followed the changes in protein expression during the entire 
differentiation process from embryonic stem cells to mature cardiomyocytes 
and demonstrated the feasibility of combining temporally and spacially 
resolved proteomics to shed light on intracellular processes at the protein 
level and their role in the organellar formation and evolvement. Subcellular 
fractions could be compared using gene ontology annotations and were 
indeed found to be enriched in proteins from the corresponding subcellular 
compartment. 
The combined peptide and protein identifications from four time points 
across five subcellular fractions could be used as an accurate mass and time 
library in combination with LC-MS from a high resolving power mass 
spectrometer to obtain high-throughput quantitative data. As yet one more 
dimension, phosphorylation or other post-translational events could be 
quantified as functions of time and space by enriching subcellular fractions 
for phosphoproteins before or phosphopeptides after enzymatic digestion. 
Due to the destructive nature of the measurement and trade-off between 
robustness and sensitivity, the single most limiting factor in such 
multidimensional analyses are the availability of cells. 
In this work, all data analysis and visualization was performed within one 
Taverna workflow, allowing automated processing of large datasets and 
sharing of the complete analysis method itself. In the most cases, the 
experimentally defined protein localization (the maximum of spectral count) 
agreed with the gene ontology annotation. However the GeneOntology 
database is not complete, and for many proteins the localization information 
has only been determined in silico. A major challenge of spatiotemporal 
proteomics is the visualization and statistical analysis of the 
multidimensional data, with a set of quantified peptides for each protein as a 
function of two coordinates (time and subcellular fraction) and comparison 
of this with other mass spectrometry or imaging data. Undoubtedly, these 
challenges will be addressed in the near future, as more and more 
researchers now undertake this type of studies and increasing numbers of 
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datasets of this type become publicly available. All data presented here is 
available in PRIDE and the Taverna workflow used for the data analysis is 
available on myExperiment. 
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The application of proteomics has expanded substantially in the past decade, 
promoting the development of new experimental techniques, 
instrumentation and data analysis methodology. Each step from raw samples 
to lists of identified peptides/proteins and their biological interpretation 
always involves a choice, conscious or not, of methodology, which is often 
dependent on decisions made at other stages of the analysis. This thesis 
emphasizes and explores the importance of these choices with regard to 
sample preparation, instrumental setup and data analysis. 
The whole course of most experiments, also in proteomics, is driven by a 
biological question. The smallest living biological unit which translates 
genomic information into proteins is the cell. The protein content of the cell 
defines and describes its type, biological state and function. Therefore it is 
logical to turn towards cell-centered proteomics.1 Unlike the genome, which 
is considered to be constant throughout the life of the cell, the proteome is 
variable in both time and space. Detailed studies including protein 
localization provide additional molecular information for a more 
comprehensive analysis. In different ways, both large-scale 
immunohistochemical efforts like the Human Protein Atlas2, 3 and mass 
spectrometry-based proteomics can produce such knowledge. The Human 
Protein Atlas project uses antibodies to generate accurate and high-
resolution information on protein localization. Ideally, one would want a 
specific reagent for each protein and for each major isoform, but this goal 
would be very difficult to achieve. On the other hand, mass spectrometry 
offers various techniques to generate information on protein localization. 
One of these is MS-imaging, which can be used to visualize compounds in 
biological tissues and may eventually be useful for clinical diagnostics. 
However, so far, commercially available instrumentation does not allow 
‘omics’ scale applications and has a limited spatial resolution capability to 
visualize proteins or other molecules at the cellular or subcellular level. 
Both strategies mentioned above provide an actual image of the cell/tissue 
at the specific state of its development. Organellar proteomics can also 
provide knowledge about protein localization, and can be more easily 
applied in time course studies providing multidimensional data on protein 
spatiotemporal dynamics. 
When approaching a particular biological question, careful choices of 
sample preparation and pre-fractionation methods are needed. In addition, 
for label-free quantitative proteomics, the choice of appropriate 
instrumentation is essential to perform the experiments well and to generate 
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data of meaningful quality. Label-free quantitation has some obvious 
advantages compared to metabolic or chemical labeling techniques: no 
artificial breakpoints in the number of the analyzed samples and no 
additional labeling step. However, it is more critically dependent on robust 
sample preparation and analytical instrumentation, and requires different 
data processing tools. State-of-the-art mass spectrometry, as described in 
Chapter 3 of the thesis, combines fast and sensitive MS/MS of ion traps 
and high accuracy and resolving power of an FTICR allowing for the 
parallel and broadband identification and quantitation of peptides. This 
method was demonstrated in a ‘textbook’ experiment of glucose-lactose 
diauxie in E. coli described in Chapter 5. The increasing popularity of 
label-free proteomics also calls for the development of better and 
reproducible sample preparation methods suitable for high-throughput work 
and large sample cohorts. This is discussed in Chapters 1 and 2 of the 
thesis. 
In the classical Design of Experiment theory, the biological question 
determines or influences the experimental methodology and instrumental 
setup. In data-driven ‘omics’ approaches, the dependency is just as strong, 
but oriented in the other direction. High-information content and high-
throughput approaches can be used for the generation of large multi-
dimensional datasets which are then used as a base for forming new 
hypotheses. The dependency between sample and data handling is also 
unequivocal. The information derived from the sample preparation and 
fractionation methods themselves can be of further use during data 
processing for learning more about the proteins or (more mundanely) 
finding and removing erroneous or uncertain identifications. The amount of 
data produced in one experiment is often measured in gigabytes, and often 
involves hundreds or thousands of individual files, demanding new tools 
and methods for efficient data processing. A simple method for accelerating 
processing of such ‘big data’ is to use virtual machines and clouds, 
temporarily acquiring the necessary computing power for a very reasonable 
cost and without physical access to the computer hardware. One method for 
this is described in Chapter 4.
The process of extracting the biologically relevant information is now much 
faster, but nonetheless still challenging. Mass spectrometry-based 
proteomics experiments are no longer imaginable without a strong 
bioinformatic and systems biology analysis. The data interpretation is one of 




framework for this purpose, the Taverna scientific workflow manager has 
been used throughout this thesis, in Chapters 1, 2, 4 and 6. Taverna 
implements automated data processing pipelines and analyses that are fully 
controllable by the researcher, but also supports and simplifies remote 
processing of large datasets on a cloud or grid. Additionally, all workflows 
can be shared online, enabling other researchers to completely repeat or 
reuse parts of the workflow for their analysis, leading to unified and more 
transparent data analysis. 
Only a few years ago, the possibility of fast, accurate and quantitative 
measurement of thousands of proteins across many samples in one 
experiment seemed to be a utopia and microarray was the only reasonably 
comprehensive method to compare two systems at different states. 
Nowadays, MS-based proteomics is a widely-accepted universal 
methodology providing miscellaneous information on molecular 
mechanisms regulating cellular systems from the point of protein function, 
localization, modification and interactions. Looking into the future, it is 
logical to expect that a large part of the increased understanding of the life 
of the cell will rest on system-wide data collection, including at the protein 
level. With time, data driven approaches in science will mature into more 
robust, more quantitative, more high-throughput and more integrative 
methods. Another and not mutually exclusive direction would probably 
involve minimization of different aspects of proteomics such as analysis 
time and required material quantity, in ideal situations enabling single-cell 
or few-cells in-depth analyses. This will require improvements in both 
hardware and software and a close partnership between different scientific 
communities. For example, for the most part, mass spectrometry hardware 
today is developed commercially. Software connects instrumentation and 
applications, and the most innovative developments are unsurprisingly 
driven by academic research groups working directly with the scientific end 
users. This seems to be a fairly natural division, which also helps 
standardization of protocols, data formats, publication requirements and 
collaboration through open-source software and shared workflows.
Proteomics harbors significant promise for medicine and human health, 
which is illustrated by a large demand for focused clinical applications and 
research areas such as regenerative medicine and cancer. Novel targeted, 
quantitative, high-throughput methods have emerged, enabling screening of 
cells for many proteins in one experiment. Affinity-based proteomics such 
as SISCAPA® 4 is a quickly arising strategy unlocking the next generation, 
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quantitative biomarker discovery. However, by going into a detailed 
analysis of the molecular mechanisms, perhaps not only a marker of the 
problem, but also more information related to its causes could be revealed. 
For this, comprehensive, spatiotemporal or organellar proteomics and 
protein-protein interaction networks research will be important. Complexes 
of multiple proteins and proteins with RNA,5 metabolites6 or other 
molecules play key roles in regulatory processes, signaling pathways and 
therefore in the functioning of the cell. 
Cell-centered approaches are focused in that they remove most issues of 
tissue or sample heterogeneity. However, any cell-based biological question 
is a complex task and requires integration of different perspectives, 
combining disciplines such as genomics, transcriptomics, proteomics, 
metabolomics and other ‘omics’ sciences. Understanding and thus 
influencing the cross-communication and dependencies between different 
domains of molecular biology within one cell or between different cells 
might lead to better diagnostics, disease prognostics and personalized 
medicine. 
This thesis clearly demonstrates that each part of a proteomics experiment 
involves important choices which influence the outcome and the 
information gained from the experiment, and that these choices are also 
interdependent. It should be emphasized that only a well-tuned combination 
of such method parameters will lead to valuable and meaningful results. 
Mass spectrometry-based proteomics has rightfully established itself in 
molecular diagnostics and fundamental research providing complementary 
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A large part of modern biology is dedicated to the functional annotation and 
interpretation of genetic information and its influence on the subject’s  
phenotype. In an attempt to obtain comprehensive information at different 
levels a number of ‘omics’ fields have emerged. Genomic and 
transcriptomic analyses provide direct knowledge of the activities of the 
genes, but the genetic content is practically constant throughout an 
organism’s body and its lifespan. The proteome on the other hand, is a 
translation of sequences encoded in the genome and the protein content is 
continuously changing, reflecting the current internal and environmental 
conditions of an organism. Proteomics describes the state of the system 
from the perspective of expression, structure, localization, interaction and 
function of the proteins. This makes proteomics research possibilities 
widely applicable. However, the absence of amplification techniques for 
proteins demands careful experiment planning with efficient and 
reproducible sample preparation procedures, especially so for a quantitative 
high-throughput label-free approach. The main challenges and difficult 
choices of the design of such experiments have been addressed in the 
General Introduction.
Proteomics is a complex field which requires a combination of various 
disciplines such as cellular biology and biochemistry for sample 
preparation, analytical chemistry for sample measurement and 
bioinformatics for the processing of data. Different chapters of this thesis 
illustrate various aspects of the proteomics pipeline and emphasize the 
importance and connection between them. Therefore the information in this 
dissertation can be divided into three major parts depicting these aspects of a 
proteomics experiment. First, sample preparation for proteomics has been 
addressed through two studies aimed at decreasing sample complexity and 
increasing proteome coverage. The second part is dedicated mostly to the 
technical step of the mass spectrometry measurement and the analysis of 
obtained spectra. The final part describes example- and proof-of-principle 
applications. 
Mass spectrometry (MS) is a powerful tool for protein analysis. However, to 
improve proteome coverage of complex samples additional pre-fractionation 
and purification steps need to be performed prior to the measurement. 
Chapter 1 presents a comparison between three pre-fractionation 
techniques performed at protein or peptide level; namely strong cation 
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exchange chromatography (SCX), isoelectric focusing (IEF) and SDS-
polyacrylamide gel electrophoresis (SDS-PAGE). All three methods were 
applied to Escherichia coli and human plasma to assess the suitability of 
each method for a particular sample, as we assume that the choice of the 
method is likely to depend on the nature the sample. In addition, each 
method provides extra information on peptide or protein properties which 
can be both measured and calculated (protein molecular weight for SDS-
PAGE, peptide pI for IEF and peptide charge at the system pH for SCX). 
These characteristics were used for the validation of peptide/protein 
identification enabling filtering for false discoveries. The whole data 
analysis from the raw data files to comparison and visualization of the 
results is interfaced in an automated manner within one pipeline using 
Taverna scientific workflow manager. 
Chapter 2 introduces a different sample de-complexation approach for 
blood plasma proteomics. Plasma is a common clinical sample containing 
countless proteins, metabolites and lipids, and is of huge interest for 
biomarker discovery. However, the large protein abundance range found in 
blood plasma is still a hurdle for proteomics analysis. The method described 
in Chapter 2 is a fast and robust depletion procedure that can be easily 
parallelized and applied in large clinical studies. It is based on a simple pH-
adjusted organic solvent precipitation, which removes up to 90% of albumin 
from the sample and increases proteome coverage by at least 25% due to 
enrichment of lower-abundant proteins, including clinically relevant 
apolipoproteins. In comparison with existing commercial solutions, the 
technique is inexpensive, reproducible, high-throughput and suitable for 
quantitative label-free proteomics. This method can also be applied to other 
samples dominated by one or more proteins by adjusting the pH to match 
their respective pI values. 
Protein quantitation is an important aspect of proteomics. Chapter 3
describes a novel MS platform for high-throughput quantitative label-free 
proteomics using a Fourier transform ion cyclotron resonance (FTICR)-ion 
trap cluster. By combining high mass accuracy and resolving power of 
FTICR for quantitation with sensitive, fast and inexpensive MS/MS analysis 
through multiple ion traps for the peptide identification, similar performance 
and throughput as multiple hybrid ion trap-FTICR instruments can be achieved 
at a lower cost. The challenges in merging data from different instruments 
based on chromatographic alignment is also discussed. &
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Although the tool for an automated method for data analysis was already 
introduced in earlier chapters (Chapters 1 and 2), mass spectral searching 
of large amounts of data acquired during the high-throughput ‘omics’ 
experiments is still limited by the computational power. Typically such data 
processing involves multiple steps using various software and data formats. 
The peptide-spectrum assignment step is especially computationally 
demanding and increases the analysis time tremendously when performed 
on standard desktop computers. Chapter 4 demonstrates the use of Taverna 
workflows for parallelized identification of tandem mass spectra through 
data decomposition algorithms applicable for publicly available database 
(X!Tandem) and spectral library (SpectraST) search tools. By outsourcing 
these processes, and thereby increasing the computational power, the 
analysis time of 5 combined human plasma datasets was reduced 30-fold for 
X!Tandem and 7-fold for SpectraST. 
The acquired knowledge and developed methods for sample preparation, 
measurement and data analysis can be applied to a large variety of 
biological questions involving different types of samples. Following a well-
studied Escherichia coli glucose-lactose diauxie experiment, in Chapters 3
and Chapter 5 the protein expression was matched with publically available 
gene expression data confirming lac operon proteins to be up-regulated. 
While Chapter 3 is a proof-of-principle study, Chapter 5 is focused on the 
implementation of the data processing pipeline for the FTICR-ion trap 
cluster and new ways of the data visualization. Quantitative information 
from ~1,000 proteins is converted to a color scale and mapped onto known 
metabolic pathways in Kyoto Encyclopedia of Genes and Genomes, 
illuminating parts of the pathway involved in the glucose metabolism. 
Similarly, this method can be applied system-wide to illustrate all the 
changes in the metabolism. Visualization of expression changes over time 
are here explored for ‘temporal’ proteomics. 
Following the study of protein dynamics, as described in Chapters 3 and 5,
the potential for studying protein expression in both time and space 
(cell/organelle) was investigated for a ‘spatiotemporal’ approach. Chapter 6 
describes the investigation of development of human stem cells into mature 
cardiomyocytes. Quantitative spatially and temporally resolved proteomics 
illuminate the mechanisms driving differentiation towards a specific end 
point. This knowledge can potentially be used to control the differentiation 
process for regenerative medicine and other purposes. In this initial study 
we separated time- and space-resolved proteomics. We extracted  whole cell 
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lysates from four time points to follow the development in time and 
enriched for cytoplasmic, membrane, nuclear, chromatin-associated and 
cytoskeletal cellular components from one time point (fetal cardiomyocyte 
state) for the spatial aspect. In the process, >40,000 peptides from ~7,000 
proteins were identified and were grouped according to their functions and 
cellular localization based on the gene ontology “slim” terms. As expected, 
proteins involved in cytoskeletal organization and motor activity were found 
to be upregulated towards later stages of cell differentiation. When adding 
an extra dimension of analysis (such as spatial components to a time course 
study), vast amounts of data are generated, creating a three-dimensional 
quantitative proteomics data cube. Unfortunately, the visualization of such 
data in a comprehendible manner is challenging. Protein abundances were 
translated into color, and mapped onto a simple representation of the cell 
which enables us to restrict the number of perspectives necessary for the 
visualization of time and space dimensions of information. In general, 
Chapter 6 demonstrates the feasibility of a spatiotemporal quantitative 
label-free proteomics. 
Moving towards proteomics which is simultaneously high-throughput, 
quantitative, spatiotemporal and label-free has become possible by 
incremental development of instrumental platforms and new ways for 
analysis and visualization of ‘big data’. Each chapter of the current thesis 




Een groot gedeelte van de moderne biologie is houdt zich bezig met de 
functionele annotatie en interpretatie van genetische informatie en de 
invloed daarvan op het uiteindelijke fenotype. Bij het verwerven van 
informatie op verschillende niveaus (metabolieten, eiwitten en genen) zijn 
verscheidene ‘omics’ velden ontstaan. Genomics en transcriptomics geven 
kennis over de activiteit van genen, maar de samenstelling van het genoom 
blijft tijdens het leven van een organisme praktisch gelijk en verschaft 
daarom weinig directe informatie over fenotypen. Het proteoom 
daarentegen is een vertaling van de genetische code en is als resultaat 
daarvan in continue verandering afhankelijk van zowel de interne als de 
omgevingstoestand van een organisme. Proteomics beschrijft daarom de 
staat van een systeem of organisme op het gebied van expressie, structuur, 
locatie, interactie en functie van de eiwitsamenstelling. Helaas is door de 
afwezigheid van amplificatietechnieken (zoals de PCR voor DNA) 
zorgvuldige planning en een efficiënte en reproduceerbare 
monstervoorbewerking van zeer groot belang, zeker in het geval van een 
label-vrije kwantitatieve strategie. De grootste uitdagingen bij het 
ontwerpen van een dergelijk experiment zijn beschreven in de Inleiding.
Proteomics is een complex onderzoeksveld dat een aantal disciplines zoals 
celbiologie en biochemie, analytische chemie en bio-informatica combineert 
voor respectievelijk, de voorbewerking, de analyse en de dataverwerking. 
De verschillende hoofdstukken van dit proefschrift belichten de 
verschillende aspecten van proteomics en benadrukken het belang van een 
goede combinatie van deze onderdelen. De informatie in dit proefschrift kan 
daarbij worden onderverdeeld in drie delen die gecorreleerd zijn aan de drie 
fasen in een proteomics experiment. Ten eerste is de monstervoorbewerking 
bekeken, in het bijzonder het verminderen van de complexiteit van een 
monster, met als doel het aantal geïdentificeerde eiwitten te vergroten. Het 
tweede deel beschrijft de techniek rond massaspectrometrie en de analyse 
van de verkregen data. Als laatste is een aantal applicaties van de volledig 
geïntegreerde aanpak beschreven. 
Massaspectrometrie is een uiterst krachtig hulpmiddel voor de analyse van 
eiwitten. Om het aantal geïdentificeerde eiwitten in een monster zo groot 
mogelijk te maken hebben zelfs op massaspectrometrie gebaseerde 
technieken een fractionering en verdere opzuivering van het monster nodig. 
Hoofdstuk 1 beschrijft de vergelijking van drie verschillende 
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fractioneringstechnieken voor de analyse van Escherichia coli en humaan 
plasma. Op grond van deze vergelijking werd vastgesteld wat de meest 
geschikte methode was voor de twee monsters, aangezien de geschiktheid 
van een analysemethode sterk afhankelijk is van het type en complexiteit 
van een monster. Verder verschaft iedere methode informatie over 
eigenschappen van het eiwit of peptide die ook berekend kunnen worden op 
grond van de aminozuursamenstelling. Deze informatie is gebruikt om de 
eventuele eiwit- of peptide identificaties te valideren op grond van de 
molecuulmassa, het iso-elektrisch punt en de peptidelading voor 
respectievelijk SDS-PAGE, iso-electric focusing en SCX chromatografie. 
Alle data analyse en verwerking is uitgevoerd in één geautomatiseerde 
methode binnen de ‘Taverna scientific workflow manager’. 
Hoofdstuk 2 introduceert een alternatieve strategie voor “de-complexering” 
van het monster voor eiwitanalyse van bloedplasma. Bloedplasma is een 
veel gebruikt klinisch monster en van groot belang voor de ontdekking van 
ziekte-indicatoren. Helaas vormt de hoge concentratie van maar een klein 
aantal eiwitten (in het bijzonder albumine) een groot probleem voor in-
depth analyse. De methode die beschreven wordt in Hoofdstuk 2 is snel en 
robuust en kan eenvoudig geparallelliseerd worden voor grote klinische 
studies. Een precipitatie-stap met een organisch oplosmiddel dat pH-
gecorrigeerd is verwijderde 90% van alle albumine. Hierdoor konden 
minimaal 25% meer eiwitten worden gemeten, waaronder apolipoproteïnen. 
In vergelijking met de commercieel verkrijgbare methoden is deze methode 
goedkoop, reproduceerbaar en geschikt voor label-vrije kwantitatieve 
analyse. Een vergelijkbare methode zou toegepast kunnen worden op andere 
monsters die gedomineerd worden door één specifiek eiwit door de pH aan 
te passen aan de pI van dit eiwit. 
De kwantificering van eiwitten vormt een belangrijk onderdeel van 
eiwitanalyses. Hoofdstuk 3 beschrijft een massaspectrometrie platform 
voor grootschalige, label-vrije kwantitatieve eiwitanalyse op basis van een 
Fourier transform ion cyclotron resonance (FTICR)-ion trap cluster. Door 
het combineren van de hoge massa-accuraatheid en resolutie van de FTICR 
voor de kwantificering en de snelle en gevoelige MS/MS-analyses van 
meerdere ion traps voor peptide identificatie, kunnen tegen lagere kosten 
prestaties gehaald worden vergelijkbaar met hybride ion trap-FTICR 
instrumenten. De uitdaging bij het samenvoegen van de data gegenereerd 
met beide type instrumenten wordt ook besproken. &
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Ondanks het feit dat geautomatiseerde methoden voor data verwerking en 
-analyse al geïntroduceerd zijn in Hoofdstuk 1 en 2 is de beperkende factor 
bij dit proces voornamelijk rekenkracht. Over het algemeen bestaat deze 
data verwerking en de daarop volgende analyse uit meerdere stappen, 
uitgevoerd in verschillende programma’s en data formats. De annotatie van 
het fragmentatiespectrum van een peptide is hierbij over het algemeen het 
meest tijdrovende onderdeel, hetgeen resulteert in lange rekentijden 
wanneer dit wordt uitgevoerd op een “normale” PC. In Hoofdstuk 4 wordt 
beschreven hoe de Taverna workflow kan worden gebruikt voor het parallel 
laten verlopen van meerdere spectra identificaties door middel van openbare 
databank (X!Tandem) of spectrum bibliotheek (SpectraST) zoekmachines. 
Door dit zoekproces uit te voeren op een rekencluster kan de tijd die nodig 
is voor de analyse van 5 humane plasma datasets met een factor 7 worden 
gereduceerd voor SpectraST en zelfs met een factor 30 voor X!Tandem 
De verkregen kennis over monstervoorbewerking, analyse en 
dataverwerking kan worden toegepast op een grote verscheidenheid aan 
biologische vragen voor sterk verschillende monsters. Hoofdstuk 3 en 5
beschrijven de vergelijking van de eiwitexpressie in een Escherichia coli 
glucose-arm experiment met public domain genexpressie data. Hierdoor kon 
bevestigd worden dat er een verhoging van de concentratie lac-operon
eiwitten plaatsvond. Waar Hoofdstuk 3 gericht is op de toepassing van de 
methode is Hoofdstuk 5 gericht op de toepassing van de data verwerking 
die nodig is voor het FTICR-ion trap cluster en op nieuwe manieren om de 
resultaten te visualiseren. De kwantitatieve informatie van circa 1000 
eiwitten is op basis van een kleurschaal gekoppeld aan de metabolisme 
routes gevonden in de ‘Kyoto Encyclopedia of Gene and Genomes’ waarbij 
vooral de routes die gekoppeld zijn aan het glucose metabolisme eruit 
sprongen. Op vergelijkbare wijze kan deze methode ook toepast worden om 
veranderingen in een systeem door de tijd (van het experiment) te volgen. 
Visualisatie van resultaten van een dusdanig experiment is in Hoofdstuk 5
ook besproken. 
In vervolg op de studies beschreven in de voorgaande hoofdstukken is in 
Hoofdstuk 6 gekeken naar de mogelijkheid om de dynamiek van eiwitten te 
bestuderen in zowel tijd als ruimte (organellen). Deze studie beschrijft de 
ontwikkeling van menselijke stamcellen tot volwassen cardiomyocyten. 
Celcultures van vier ontwikkelingsfasen zijn gelyseerd en voor één tijdspunt 
(foetaal cardiomyocyten) zijn de verschillende organellen fracties 
geïsoleerd: cytoplasma, membraam, nucleus, chromatine-gerelateerd en 
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cytoskelet. De kwantitatieve eiwitdata in zowel tijd als ruimte laten de 
verschillende mechanismen zien die actief zijn tijdens de differentiatie. 
Deze kennis over de differentiatie kan in de toekomst mogelijk gebruikt 
worden om dit proces te kunnen controleren, bijvoorbeeld voor 
regeneratieve geneeskunde. Binnen de gehele studie zijn er >40.000 
peptiden en ongeveer 7.000 eiwitten geïdentificeerd en deze zijn vervolgens 
gegroepeerd op basis van hun functie en locatie. Zoals verwacht, was te zien 
dat eiwitten die betrokken zijn bij de organisatie van het cytoskelet en bij de 
motorfunctie in de latere fasen van ontwikkeling in concentratie toenemen. 
Wanneer er, zoals in deze studie, een ruimtelijk aspect wordt toegevoegd 
aan een tijdstudie, ontstaan er immense hoeveelheden data die op een 
driedimensionale manier met elkaar zijn gecorreleerd. Helaas is het op een 
inzichtelijke manier weergeven representeren van deze data erg moeilijk. Er 
is hiervoor gekozen de relatieve eiwitconcentratie te vertalen naar kleuren 
en vervolgens te koppelen aan delen van een versimpelde representatie van 
een cel. Op deze manier is het mogelijk om de driedimensionale data zoals 
verkregen wordt bij een studie met een tijd- en ruimte-aspect weer te geven 
in een tweedimensionaal format. Over het geheel toont Hoofdstuk 6 de 
potentie van het gebruik van label-vrije kwantitatieve eiwitanalyse voor 
dergelijke tijd- en ruimte-studies. 
Door stapsgewijze ontwikkeling van technieken en technologie, en het 
weergeven van informatie uit grote datasets laat dit proefschrift zien dat het 
mogelijk is grootschalige, label-vrije, kwantitatieve, tijd- en ruimte-studies 
uit te voeren op eiwitniveau. Elk hoofdstuk in dit proefschrift beschrijft één 
of meerdere delen van deze ontwikkelingen met de uiteindelijke toepassing 
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